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ABSTRACT 
 
The burgeoning field of additive manufacturing, or “3D printing”, centers on the idea of 
creating three-dimensional objects from digital models. While conventional manufacturing 
approaches rely on modifying a base material via subtractive processes such as drilling or 
cutting, 3D printing creates three-dimensional objects through successive deposition of two-
dimensional layers. By enabling rapid fabrication of complex objects, 3D printing is 
revolutionizing the fields of engineering design and manufacturing. This thesis details the 
development of a projection-based stereolithographic 3D printing apparatus capable of high-
resolution patterning of living cells and cell signals dispersed in an absorbent hydrogel polymer 
matrix in vitro. This novel enabling technology can be used to create model cellular systems that 
lead to a quantitative understanding of the way cells sense, process, and respond to signals in 
their environment.  
The ability to pattern cells and instructive biomaterials into complex 3D patterns has 
many applications in the field of tissue engineering, or “reverse engineering” of cellular systems 
that replicate the structure and function of native tissue. While the goal of reverse engineering 
native tissue is promising for medical applications, this idea of building with biological 
components concurrently brings about a new discipline: “forward engineering” of biological 
machines and systems. In addition to rebuilding existing systems with cells, this technology 
enables the design and forward engineering of novel systems that harness the innate dynamic 
abilities of cells to self-organize, self-heal, and self-replicate in response to environmental cues. 
This thesis details the development of skeletal and cardiac muscle based bioactuators that can 
sense external electrical and optical signals and demonstrate controlled locomotive behavior in 
response to them. Such machines, which can sense, process, and respond to signals in a dynamic 
environment, have a myriad array of applications including toxin neutralization and high 
throughput drug testing in vitro and drug delivery and programmable tissue engineered implants 
in vivo. 
 A synthesis of two fields, 3D printing and tissue engineering, has brought about a new 
discipline: using microfabrication technologies to forward engineer biological machines and 
systems capable of complex functional behavior. By introducing a new set of “building blocks” 
into the engineer’s toolbox, this new era of design and manufacturing promises to open up a field 
of research that will redefine our world.  
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CHAPTER 1: INTRODUCTION 
 
1.1 MOTIVATION  
 The advent of 3D printing additive manufacturing technologies has revolutionized 
engineering design and manufacturing in recent years. The use of these technologies to 
manufacture products with traditional engineering materials such as metals and plastics is being 
extensively explored and promises to permeate through all aspects of industry. The concurrent 
rise of tissue engineering, a new era of biological and biomedical engineering, has given rise to 
the concept of “building with biology”. This field is centered on the idea that scientists and 
engineers can combine cells and instructive biomaterials to fabricate complex biological 
substitutes for native tissue and organs. This thesis presents a synthesis of these two rapidly 
evolving fields: using 3D printing technology to microfabricate biological machines and systems 
capable of complex sensing and actuation behaviors. 
 
1.2 OVERVIEW 
 This thesis presents the development of a high-resolution stereolithographic 3D printing 
apparatus designed to replicate complex cellular microenvironments, followed by a 
demonstration of microfabricated skeletal and cardiac muscle based biological machines 
controlled via external electrical and optical signaling. 
Chapter 2 begins with a literature review of stereolithographic 3D printing processes and 
their applications in engineering 3D cell culture systems. This is followed by a review of 
“reverse-engineered” biological systems for applications in tissue engineering and regenerative 
medicine, and then a review of “forward-engineered” biological systems for applications in 
biosensing and bioactuation.  
Chapter 3 outlines the development of a projection stereolithography-based 3D printing 
system that is capable of printing cells and instructive biomaterials at high resolution.  
Chapter 4 presents forward-engineered biological machines powered by the actuation of 
engineered skeletal and cardiac muscle. 
Chapter 5 describes future directions in the new field of microfabricating biological 
machines and systems, followed by a discussion on novel applications of this technology. 
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CHAPTER 2: REVIEW OF ENGINEERED BIOLOGICAL SYSTEMS 
 
2.1 MICROFABRICATION OF BIOLOGICAL SYSTEMS 
 
2.1.1 CELL INTERACTIONS WITH 3D MATRICES 
Cells in native tissue are arranged in complex three-dimensional structures and 
surrounded by a range of biological, chemical, and mechanical signals that are specifically tuned 
to evoke certain functional responses. The boundary conditions imposed by the highly structured 
microenvironment of cells in live tissues and organs affect cell architecture and function (Watt 
2013). Indeed, it has been shown that cellular phenotype can even supersede genotype as a result 
of interaction with the extra-cellular matrix (ECM) that surrounds cells in vivo (Petersen 1992). 
 Conventionally, cells cultured in monolayers upon stiff flat substrates such as plastic or 
glass petri dishes have served as representative models of the functional behavior of native 
tissue. These models have provided researchers with much insight into many biological 
phenomena. Pioneering studies on the effect of 2D substrate stiffness on the directed 
differentiation of plated stem cells (Engler 2006) and the mechanical interactions that lead to 
changes in cell growth and apoptosis (Chen 1997) have contributed greatly to the field’s 
understanding of the functional behavior of a cell. 
However, it is well recognized that the range of complex signaling mechanisms and 
three-dimensional cell-cell and cell-matrix interactions found in real tissue cannot be replicated 
by these two-dimensional models (Pampaloni 2007). In fact, studies of cells embedded in 3D 
matrices have been shown to demonstrate significantly different functional behavior than present 
in the conventional 2D case (Fraley 2010). Studying the 3D communication network regulating 
cell-matrix interactions in native tissue can thus lead to an improved understanding of the 
physiological mechanisms underlying cell growth, proliferation, migration, differentiation and 
even tissue organization and remodeling on the macro-scale (Cukierman 2002).   
Experimental studies of three-dimensional morphology and phenomena in cellular 
systems have primarily been conducted in live animals, but there are many limitations on the 
experimental flexibility allowed in such in vivo studies. The challenging task of reliable imaging 
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and data collection inside live animals, for example, renders these experiments difficult to 
characterize and indicates the need for an alternative approach to studying cells in 3D models.  
The underlying challenge in this field is, therefore, to fabricate 3D in vitro cell culture 
systems that can mimic the morphology and functional behavior of native tissues better than 
conventional 2D monolayer cultures. This promises to provide a quantitative understanding of 
the mechanisms underlying the way cells sense, process, and respond to signals in their 
environment. Such systems have applications in fundamental studies of extracellular matrix 
interactions (Thery 2010), organ-on-a-chip methods for drug screening of physiologically and 
phenotypically relevant substitutes for native tissue (Huh 2010), programmable tissue 
engineering for applications regenerative medicine (Andersson 2004), and the development of 
biological sensors and actuators (Kamm 2013). All these applications require an enabling 
microfabrication technology that is capable of patterning cells and cell signals at high resolution 
in a 3D environment. 
 
2.1.2 STEREOLITHOGRAPHIC 3D PRINTING 
 An array of rapid prototyping technologies, titled “3D Printing”, have revolutionized the 
design and fabrication processes in the manufacturing sector. As compared to conventional 
subtractive manufacturing methods, these novel technologies are all based on an additive 
manufacturing process in which parts are built layer-by-layer from the bottom up. This enables 
the fabrication of complex designs with high scalability and minimized material waste. Additive 
manufacturing processes have been used to print powder materials (Selective Laser Sintering), 
solid materials (Laminated Object Manufacturing), liquid materials through extrusion processes 
(Fused Deposition Modeling) and liquid materials through polymerization processes 
(Stereolithography) (Bartolo 2011).  
 Stereolithographic 3D Printing, developed by 3D Systems in 1986, is a solid freeform 
fabrication technology based on the polymerization of photopolymer resins via exposure to light. 
As with most additive manufacturing technologies, the first step in fabricating a 3D structure by 
stereolithography is to create a digital model of the part, using computer aided design software 
(CAD) or a 3D digital scanner. The model is then converted to a standard tessellation language 
file format (STL) that describes the surface geometry of the 3D model. Specialized software is 
	  
	   4	  
used to virtually slice the model into sequential layers. The resulting information is then sent to 
the stereolithography apparatus (SLA) for layer-by-layer fabrication (Melchels 2010).  
 Two main schemes of stereolithography apparatus have been implemented in the 
fabrication of 3D photopolymer structures: scanning laser systems and digital light projection 
based systems. In the first of these schemes, a computer-controlled laser beam is rasterized 
across the photopolymer resin and cures 2D cross-sections of a 3D structure in a sequential 
manner. In digital light projection based systems, spatial light modulators such as digital micro-
mirror devices are used to project 2D pixel patterns, allowing entire cross-sectional layers to be 
polymerized at once (Figure 2.1). Both these schemes are compatible with microfabricating 3D 
biological systems, but they require photopolymer resins with advantageous properties.  
 
 
Figure 2.1: A) 3D Designs are sliced into sequential 2D cross-sections for layer-by-layer 
fabrication. B) Laser-based (left) and digital light projection based (right) systems are the most 
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2.1.3 HYDROGELS AS SYNTHETIC SCAFFOLDS FOR 3D CELL CULTURE SYSTEMS 
 There are a limited number of photopolymer resins for stereolithography that are 
compatible with applications in bionanotechnology. Among the most promising of these resins 
are the class of highly absorbent cross-linked polymeric structures known as “hydrogels”. 
Hydrogels are a class of materials in which monomers undergo chemical and physical cross-
linking to form polymer networks that are hydrophilic and biocompatible. The structural and 
functional properties of hydrogels, such as porosity and swelling behavior, can be readily 
tailored via modifications to the monomers on which their polymeric network is based. The 
porous and absorbent nature of these materials facilitates the diffusion of signals and nutrients 
through the polymeric network, leading to their wide use in biological and biomedical 
applications (Stampfl 2011). These solvent-swollen cross-linked polymer networks also have the 
ability to respond to changes in temperature, pH, illumination, or other physical and chemical 
stimuli. This is particularly advantageous for biomedical applications that rely on real-time 
response behavior such as dynamic medical implants or bioactuators that generate force in 
response to external stimuli (Hinkley 2004).  
 The suitability of hydrogels as synthetic scaffolds for engineering three-dimensional 
substitutes for native tissue and organs has been extensively explored in the literature (Peppas 
2006). The mechanical properties of hydrogels resemble those of natural tissues, rendering them 
particularly attractive for applications in programmable tissue engineering. Cells that have been 
encapsulated in natural hydrogels, such as collagen and fibrin, as well as synthetic hydrogels 
such as poly (ethylene glycol) diacrylate, have been shown to survive and proliferate within 
these matrices in long-term studies. Natural hydrogels have the advantage of promoting cellular 
functions via a myriad of endogenous factors that are advantages for the viability and 
development of cells. Synthetic hydrogels have the advantage of having very well defined and 
tunable material properties that can be readily studied to determine the effect of individual 
signals on cellular function (Tibbit 2009).  
Many synthetic hydrogels that have been tested as 3D cell culture platforms. Of these, 
poly (ethylene) glycol diacrylate (PEGDA) hydrogels are promising in their ability to maintain 
viability of encapsulated cells and sustain proliferation in vitro (Bryant and Anseth 2002, 
Williams 2003, Yeh 2006). Such hydrogels can be conjugated with bioactive moieties that 
enable different functional behaviors such as universal or cell-type selective adhesion and 
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targeted enzymatic degradation (Figure 2.2). These properties render PEGDA an attractive 
biomaterial for fundamental studies of cell mechanics and applications in tissue engineering, 
regenerative medicine, and drug delivery (Stephens-Altus 2011).  
 
 
Figure 2.2: A) Addition of acrylate groups to PEG polymers generates the underlying structure 
for fabricating photocrosslinkable hydrogels. B) Incorporation of bioactive moieties, such as the 
Arg-Gly-Asp-Ser (RGDS) peptide series, can render hydrogels cell adhesive. C) 
Photocrosslinkable PEGDA hydrogels can be polymerized via exposure to ultraviolet light in the 
presence of a photoinitiator (Stephens-Altus 2011). 
 
2.1.4 STEREOLITHOGRAPHIC MICROFABRICATION OF 3D CELL CULTURE SYSTEMS  
 Many researchers have investigated the microfabrication of poly (ethylene glycol) 
diacrylate (PEGDA) structures using 3D printing approaches (Ovsianikov 2010, Gaebel 2011). 
The studies that have proven most successful in their ability to encapsulate cells in 3D Printed 
PEGDA hydrogels have been based on stereolithography systems. Initial studies in this field 
utilized laser-based stereolithographic systems in which cells mixed with PEGDA prepolymer 
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solution were patterned via curing of the photopolymer in response to visible or ultraviolet light 
exposure (Figure 2.3) (Arcaute 2006, Chan 2010, Zorlutuna 2011). Photoinitiators that operate in 
the visible and ultraviolet regime have been well characterized for their effect on cure kinetics 
and cell toxicity in multiple studies (Williams 2005, Fairbanks, 2009, Bryant 2012). Of these, the 
visible light photoinitiator lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) and the 
ultraviolet light photoinitiator 2-hydroxy-1-[4-(2-hydroxyethoxy) phenyl]-2-methyl-1-propanone 
(I2959) are the most commonly used for encapsulation of living cells in 3D PEGDA polymeric 
networks (Fairbanks 2009). 
 
 
Figure 2.3: A) Schematic representation of cell encapsulation in PEGDA hydrogels via 
conventional laser-based stereolithography apparatus systems. B) 3D multi-material patterning of 
viable cells stained with either CellTracker® CMFDA (green) or CMTMR (orange) dye. Scale 
bars are 1mm. C) Viability of fibroblasts assessed over a period of 14 days for cells encapsulated 
in PEGDA hydrogels of varying molecular weights with or without incorporation of bioactive 
RGDS peptide sequence moieties (Chan 2010).  
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 Recently, the development of projection micro-stereolithography systems (µSLA) have 
demonstrated the ability of this high-throughput, scalable technology to pattern photopolymers in 
complex 3D architectures (Sun 2005, Choi 2009, Xia 2009). These µSLA systems 
conventionally rely on a digital micro-mirror device (DMD) to serve as a dynamic mask for 
polymerization. This technology soon developed to include studies of patterning biocompatible 
polymers as scaffolds for 3D cell culture (Zhang 2012, Gauvin 2012, Grogan 2013, Lin 2013) as 
well as studies of cells encapsulated in hydrogel polymeric networks via µSLA (Soman 2013). 
 Most stereolithography systems used to encapsulate cells in hydrogels, both laser-based 
and digital light projector-based, rely on thorough mixing of the cells in the prepolymer solution 
to evenly distribute cells throughout the polymerized structure. These techniques offer some 
control over the architecture of cell-cell interactions within a polymerized hydrogel network, but 
a greater degree of precision over cell patterning enables more rigorous studies of cell mechanics 
and functionality in vitro. To this end, researchers have attempted to integrate higher precision 
cell patterning techniques in tandem with hydrogel photopolymer patterning. Examples of these 
techniques include biochemical surface modification of hydrogels via controlled protein 
patterning (Hynd 2007, Chan 2012), optical trapping of live cells followed by encapsulation in 
photopolymerizable hydrogels (Chiou 2005, Mirsaidov 2008, Linnenberger 2013), 
dielectrophoretic control of live cells followed by encapsulation in photopolymerizable 
hydrogels (Fan 2008, Bajaj 2012), and even magnetic cell levitation in 3D hydrogel tissue 
culture systems (Souza 2010). 
 Since the development of 3D printing technologies, the advantages of this novel additive 
manufacturing approach have been demonstrated for applications in a wide array of disciplines. 
The application of stereolithographic 3D printing to encapsulation of living cells in hydrophilic 
and biocompatible polymeric hydrogel networks have established this technology as an enabling 
tool in the field of biological and biomedical engineering. By giving researchers the ability to 
precisely control the spatiotemporal architecture of cell-cell and cell-matrix interactions as 
governed by physiology, the use stereolithography for fabricating 3D cell culture systems 
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2.2 TISSUE ENGINEERING: REVERSE ENGINEERING OF BIOLOGICAL SYSTEMS 
 
2.2.1 INTRODUCTION TO CHALLENGES AND OPPORTUNITIES IN TISSUE ENGINEERING 
 One of the major applications of microfabrication of 3D cell culture systems is in the 
field of tissue engineering. Tissue engineering aims to create complex biological substitutes for 
native tissue using a combination of cells and instructive biomaterials. This emerging field 
promises to revolutionize modern medicine by providing an alternative to tissue and organ 
transplantation, and perhaps eliminating the need for transplants altogether by aiding the rapid 
development and testing of new drugs and therapies (Griffith 2002).  
 The conventional approach to tissue engineering has been the fabrication of porous 
degradable scaffold structures as platforms for cell seeding. In these studies, the scaffolds are 
often generated using conventional microfabrication approaches for patterning natural and 
synthetic materials (Zhang 2005). Researchers have even explored approaches in which 
cadaveric tissue is de-cellularized and repopulated with living cells to yield functional tissue and 
whole organs (Figure 2.4) (Ott 2008, Song 2013).  
 
 
Figure 2.4: Cadaveric rat hearts perfused with SDS over a period of 12 hours yield de-
cellularized scaffolds that maintain the large vasculature conduits present in vivo (represented by 
black asterisks in H&E stain). Repopulation of these scaffolds with living cells yielded 
macroscopic contraction of tissue engineered hearts (Ott 2008). 
 
These scaffold-based approaches have the advantage of placing cells within a precise 
morphological design while maintaining the cell-cell and cell-matrix interactions that are seen in 
vivo. However, these approaches come with the challenges of regulating the distribution of cells 
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within the scaffolds, as well as the inability to engineer adequate vascular networks that can 
provide supplies of nutrients to large-scale engineered tissues. These challenges render scaffold 
based “top down” approaches undesirable for applications in tissue engineering of complex 
tissues and organs, as they are unable to provide precise spatial control of cells and biochemical 
signals in three dimensions (Andersson 2004).  
 The rise of “bottom up” approaches in microfabrication, triggered by the advent of 
additive manufacturing technologies, provides an attractive alternative approach to 
manufacturing complex biological substitutes for native tissue and organs. Assembling tissues 
layer by layer from the bottom up using 3D printing technology will allow for complex three-
dimensional control over the morphological and functional properties of engineered tissue. 
Additionally the scalability, high reproducibility, cost effectiveness, and ease of customization of 
3D printing technologies render this an attractive approach to providing individually tailored 
biological substitutes for native tissue. 
 
2.2.2 3D PRINTED 3D CELL CULTURE SYSTEMS FOR TISSUE ENGINEERING 
 Many microfabrication approaches for tissue engineering applications have been 
explored in recent years. These approaches come with the advantage of high-throughput and 
reproducible experimentation that offers precise spatiotemporal control of cell signaling and 
culture conditions in vitro. Applications of such technologies in the field of pancreatic, liver, 
cartilage, vasculature, nerve tissue, cardiac and skeletal muscle engineering have demonstrated 
rapid progress towards the goal of reverse engineering native tissue and organs (Khademhosseini 
2006, Park 2007, Vunjak-Novakovic 2010).  
 Pioneering studies in bottoms-up tissue engineering have used 3D bio-printing to deposit 
“bio-ink” spheroids containing live cells into a supportive hydrogel environment and allowing 
the printed cells to self-assemble into topologically defined three-dimensional structures (Figure 
2.5) (Mironov 2007, Jakab 2008, Norotte 2009). These techniques allow cells to be arranged at 
high densities in physiological relevant morphologies and culture conditions. Similar systems 
that build tissue layer by layer from the bottom up via inkjet or nozzle based printing systems 
have proved promising for engineering cartilage and bone in vitro (Cohen 2006, Boland 2006). 
While many of these technologies are able to engineer tissue constructs with spatially 
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homogenous material and functional properties, they are still far from achieving the degree of 
complex 3D control required to replicate native tissue architecture (Sawkins 2013). 
 
 
Figure 2.5: A) “Bio-ink” spheroids printed into a circle fuse into a 3D toroid after ~60 hours; B) 
Schematic of 3D tissue constructed via sequential layer-by-layer spheroid deposition and fusion. 
 
 The stereolithographic 3D printing systems presented earlier in this chapter are ideal 
candidates for targeting applications in bottom-up tissue engineering. SLA systems have 
demonstrated capabilities in high resolution patterning of photopolymers and have the 
advantageous property of being able to encapsulate cells in polymeric networks while preserving 
viability and functionality in long-term studies. Additive photopatterning of PEGDA hydrogels 
has been shown to be a viable method of engineering 3D substitutes for native tissue (Tsang 
2007, Du 2008). The use of SLA based systems for directing the growth of microvasculature 
have also been explored, promising to provide perfusable networks for nutrient supply in large-
scale structures (Jeong 2012). However, much remains to be explored in the field of 
stereolithographic 3D printing systems that specifically target engineering substitutes for native 
tissue and organs. This enabling microfabrication technology thus promises to drive the next era 
of programmable tissue engineering for applications in medicine and biology. 
 
	  
	   12	  
2.3 BIOLOGICAL MACHINES: FORWARD ENGINEERING OF BIOLOGICAL SYSTEMS 
 
2.3.1 INTRODUCTION TO FORWARD-ENGINEERED LIVING MACHINES 
 The field of reverse engineering biological systems for applications in tissue engineering 
and regenerative medicine has garnered much success in recent years. However, progress in this 
field is hampered by the lack of fundamental understanding on how cell-cell and cell-matrix 
interactions in complex 3D networks lead to larger, system-level functional response. It is 
anticipated that studies that focus on building novel biological systems from the “bottom up” will 
allow researchers to capture the complex interactions between systems at the micro- and macro-
scale. Reverse engineering as a method for recapitulating the structure of existing biological 
tissues and organs goes some way towards addressing the challenges in this field. However, it 
has also driven the formation of a new field in tandem: “forward engineering” of biological 
machines and systems. 
Forward engineering is focused on designing novel systems that harness the innate 
dynamic abilities of biological systems to self-organize and respond to environmental cues. The 
ultimate goal of these efforts is to engineer integrated cellular systems, or “living machines”, that 
combine knowledge from the diverse disciplines of engineering design and manufacturing, 
bionanotechnology, tissue engineering, and synthetic biology to sense, process, and respond to 
signals in a dynamic environment. Such multi-functional machines, built from the modular 
components of biological tissue, can address many challenges and applications (Kamm 2013). 
Applications in cell-based soft robotics, in which living machines are designed to accomplish 
such objectives of robotics as sensing, storage and processing of signals, and a resultant response 
such as actuation, have generated much interest in recent years. 
 Perhaps the most intuitive demonstration of a “living machine” is a biological system that 
can generate force and produce motion. To that end, many studies have explored the use of 
existing biological components as power sources that drive the actuation of machines of multiple 
length scales ranging from the nano- to macro-scale regimes. Pioneering studies in this field 
investigated nano-scale actuation of the motor proteins kinesin and myosin, which use adenosine 
triphosphate (ATP) as a source of fuel for generating force and demonstrating motility (Vale 
1985, Spudich 1994). Applications of such molecular motors as nano-scale machines have been 
explored, in which the tension-sensing capabilities of myosin motors demonstrate its 
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advantageous properties as a molecular force sensor (Laakso 2008). Further studies in this field 
delved deeper into applications of existing biological systems as actuators by employing strands 
of DNA molecules to drive the actuation of nano-machines. In these machines, strands of DNA 
assembled to form shapes resembling tweezers were placed in solution with auxiliary strands of 
“fuel” DNA. The subsequent hybridization of DNA strands generated force and drove opening 
and closing of the tweezer-like living machines (Figure 2.6A) (Yurke 2000, Simmel 2001). 
 On the micro-scale, single cells or swarms of cells have been used to drive the actuation 
of robotic devices in fluidic systems. Bacterial cells have been shown to generate force and drive 
actuation and locomotion of micro-scale robotic devices (Martel 2006). Control of these bacterial 
cells via magnetotactic and chemotactic mechanisms have opened up applications in which 
living machines can sense and process external signals in order to generate a resultant response 
(Kim 2012). Similarly, researchers have explored the use of motile sperm cells as actuators for 
locomotion of micro-robots. In these studies, the force production of sperm flagella has been 
used as a biological power source for motility in a fluidic environment (Magdanz 2013).  
 Use of existing biological components on larger scales, corresponding to the size of 
living tissue and organs, have also been explored as actuators for macro-scale devices. Recent 
studies that investigate the use of heart muscle tissue excised from live insects as a source of fuel 
have demonstrated that the spontaneous contraction of this tissue can drive actuation of tweezer-
like manipulators (Figure 2.6B) (Akiyama 2013).  
 
Figure 2.6: A) Tweezer-like living machine powered by the hybridization of DNA strands 
(Yurke 2000); B) Tweezer-like bio-hybrid machine powered by the contraction of heart muscle 
tissue excised from a live insect (Akiyama 2013).  
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 Living machines that are powered by existing biological systems, as explored in the 
previous sections, are advantageous in that they demonstrate the ability to fabricate soft robotic 
devices that are driven by a variety of easily controllable signals and have the dynamic response 
and self-healing properties found in biological systems. However, because they rely on the direct 
use of existing systems, they limit the design parameters of micro-robotic devices. True forward 
engineering of living biological machines requires a greater degree of control over the design and 
functionality of bioactuators. These machines could even potentially surpass the force generation 
and actuation behaviors found in native tissue, leading to a new era of design in which biological 
materials will be an accepted component of every engineer’s “toolbox”. 
 
2.3.2 CARDIAC MUSCLE AS A BIOACTUATOR  
 Cardiac muscle in vivo is designed to act as a pump that drives blood flow through 
vasculature. The high density of cells in native myocardium allows for the formation of a 
syncytium, enabling the coordinated propagation of electrical signals that leads to synchronous 
contraction of the tissue (Vunjak-Novakovic 2010). This advantageous property renders cardiac 
muscle an attractive tissue for applications in bioactuation. 
 Tissue engineered cardiac muscle tissue for applications in regenerative medicine have 
been studied extensively in recent years, as the need to restore contractile function to hearts upon 
myocardial infarction, or “heart attack”, is of great importance to the medical community. 
Studies have shown that engineered cardiac tissue grafts implanted onto infarcted rat hearts can 
electrically couple with native tissue and improve the systolic and diastolic function of diseased 
myocardium in vivo (Figure 2.7) (Zimmerman 2006). This and other studies have provided 
evidence that engineered cardiac tissue can mimic the contractile function of native tissue, 
leading to ongoing human clinical trials focused on using engineered muscle tissue to treat 
cardiomyopathy. 
 Since the contractile behavior of muscle tissue is driven by the propagation of electrical 
signals known as action potentials, engineered cardiac muscle tissue can be stimulated and paced 
in vitro via electrical signals that mimic those in native heart tissue. Electrical signaling during 
development of engineered tissue has even been shown to enhance the cell differentiation and 
functional assembly of the tissue, leading to the formation of conductive and contractile 
properties that mimic native myocardium (Radisic 2004). Such tissues have been explored as 
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useful tools for applications in disease modeling and high-throughput drug screening in vitro. In 
these studies, engineered cardiac tissues that have been exposed to drugs with known cardiotoxic 
effects and stimulated via electrical signaling demonstrate dose-dependent contractile responses 
to the administered drugs. The ability to control the contraction and pacing of engineered cardiac 
tissue with electrical stimulation thus has many practical applications (Iyer 2011). 
 
 
Figure 2.7: A) Multiple loops of engineered heart tissue combine to form a contractile tissue 
graft; B) Tissue grafts implanted onto infarcted rat hearts support contractile function. 
 
 Conventional approaches to engineering cardiac tissue have focused on either the cell 
sheet engineering approach or the cell scaffold approach. The cell sheet engineering approach 
generally involves plating a sheet of cardiac tissue on a 2D substrate, promoting the formation of 
planar cell-cell junctions that help the tissue beat in synchrony upon electrical stimulation. Such 
tissues have recently been used as actuators for locomotion of biorobotic devices.  
A pioneering study in this field engineered a sheet of cardiac tissue on a synthetic 
elastomer designed to form a quasi-closed “bell” structure. Electrically controlled contraction of 
the engineered cardiac tissue alternately contracted and relaxed the elastomer body, leading to 
propulsive swimming behavior that mimicked the movement of jellyfish (Figure 2.8A). 
Qualitative and quantitative comparisons of this biomimetic movement to that of real jellyfish 
demonstrated that the engineered system was able to replicate the momentum transport and body 
lengths traveled per swimming stroke of the natural system (Nawroth 2012).  
Another study in this field engineered sheets of cardiac tissue on hydrogel cantilevers 
fabricated using a 3D printer (Figure 2.8B). The autonomous and synchronous contraction of the 
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cardiomyocytes led to a change in conformation of the cantilever structures, leading to an inch 
worm-like biomimetic walking motion (Chan 2012).  
Similar studies of engineered cardiac tissues seeded on hydrogel substrates have 
investigated the effects of incorporating nano-scale fibers and carbon nanotubes into the 
hydrogel substrates. These embedded materials improve the mechanical integrity of the substrate 
material and, by providing the engineered tissue with an electrically conductive nanofibrous 
architecture that mimicked the in vivo environment, been shown to enhance the functional 
performance of cardiac cell sheets (Kharaziha 2013, Shin 2013). 
 
 
Figure 2.8: A) Engineered sheet of cardiac muscle seeded on a soft substrate, termed a 
“medusoid” fuels a propulsive swimming mechanism in this living machine that mimics the 
motion of a jellyfish (Nawroth 2012). B) Engineered sheet of cardiac muscle seeded on a 3D 
printed hydrogel structure drives an inch-worm like biomimetic crawling motion across a 
substrate (Chan 2012). 
 
 An alternative to engineering sheets of cardiac tissue has been engineering cells in a 
scaffold to form a 3D strip of muscle. A pioneering study in this field seeded cardiomyoctes in a 
collagen gel cast to form ring-like 3D structures capable of contractile function. These 
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engineered tissues displayed electrophysiological properties similar to those found in native 
cardiac tissue (Eschenhagen 1997). More recent studies of engineered cardiac microtissues 
seeded in fibrin and collagen gels have investigated the functional behavior of these tissues. In 
these studies, engineered cardiac tissue is tethered to cantilevers that deflect in response to 
muscle contraction (Boudou 2011). In addition to acting as a force sensor, such cantilever-based 
mechanisms demonstrate the use of engineered cardiac tissue as a bioactuator capable of force 
generation and contractility.  
Thus, while engineering of cardiac tissue has historically been driven by applications in 
regenerative medicine, the studies generated in this field have demonstrated the power of cardiac 
muscle to act as an actuator for other applications. It is anticipated that the future of forward-
engineered bio-robotic devices will utilize engineered cardiac tissue as a source of fuel and force 
production. 
 
2.3.3 SKELETAL MUSCLE AS A BIOACTUATOR  
 While cardiac muscle tissue has many advantageous properties that make it an appealing 
choice for bioactuator applications, much research has been done in tandem on the use of skeletal 
muscle tissue for applications in this field. Skeletal muscle in vivo has a highly organized and 
hierarchical tissue architecture. Individual muscle cells, termed myoblasts, differentiate into 
multicellular elongated structures, myotubes, which are capable of contractility. These myotubes 
form muscle fibers that are aligned in bundles termed fascicles. The muscle fascicles in turn 
combine to form the macro-scale structure of skeletal muscle. This high degree of organization 
and alignment on the micro- and macro-scale allows skeletal muscle to efficiently generate force 
and produce motion. Indeed, skeletal muscle can generate over 200 kPa of stress and sustain 
20% strain, properties that no currently available actuator of a similar size can mimic (Neal 
2013). Unlike cardiac tissue, skeletal muscle does not show significant spontaneous contractile 
behavior, making it easier to control the contractility of engineered skeletal muscle tissue via 
external signaling. Furthermore, skeletal muscle cells can interface with multiple cell types, such 
as neurons and endothelial cells, making them an ideal platform for forward-engineering 
integrated cellular systems.  
 A pioneering study in the engineering of skeletal muscle tissue formed a sheet of primary 
muscle cells isolated from a rat and allowed the sheet to roll into a 3D strip of muscle capable of 
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contractility and force generation in response to electrical signaling (Dennis 2000). This study 
was followed by experiments that investigated contractile behavior of muscle cells seeded in 
synthetic extracellular matrices such as fibrin gels, which have a stiffness similar to that of native 
muscle tissue (Huang 2005, Khodabukus 2009). Electrical stimulation of these engineered 
muscle tissues demonstrated that engineered muscle is capable normal physiological function in 
length-tension and force-frequency relationships. However, engineered muscle produces 
significantly less force per unit cross-sectional area as compared to native skeletal muscle.  
Investigations of the biological architecture of engineered skeletal muscle tissue have 
shown that engineered tissue mimics native tissue by forming striated sarcomere structures, the 
smallest contractile units found in skeletal muscle (Fujita 2007). Moreover, muscle cells cultured 
in fibrin gels subjected to strain formed highly aligned myotubes and bundle-like structures in 
the direction of the applied strain, similar to morphology seen in vivo (Matsumoto 2007).  
Building on this early work, studies of muscle cells in fibrin gel matrices investigated the 
use of microfabricated molds to guide the alignment and differentiation of densely packed 
myofibers (Bian 2009). Increased alignment of muscle fibers in engineered tissue led to a 
significant corresponding increase in the force produced by the tissue constructs (Lam 2009). 
Furthermore, directed patterning of mechanical stress in these engineered tissue structures led to 
the formation of controllable gradients of extra cellular matrix protein compositions and 
organization with 3D engineered tissue (Legant 2009).  
The matrix compositions of both fibrin and collagen gels that lead to force generation 
capacity comparable to native tissue has been extensively characterized and optimized (Hinds 
2011). These and other studies have contributed to significant advances in this field, providing 
researchers with the ability to engineer skeletal muscle tissue that reproducibly mimics the 
complex morphological organization and functional behavior of native tissue (Figure 2.9). The 
ability of these engineered tissues to efficiently generate force and produce motion makes them 
ideal bioactuators for applications in forward-engineered robotics. 
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Figure 2.9: A) Bioengineered skeletal muscle bundle formed within synthetic hydrogel capable 
of force generation and contractility; B) Highly organized structure of engineered muscle shows 
aligned multi-nucleated myotubes (red nuclei) exhibiting cross-striations characteristic of 
sarcomeric structures in vivo (red) (Hinds 2011). 
 
2.3.4 CONTROLLED BEHAVIOR OF FORWARD ENGINEERED BIOACTUATORS 
 In order for engineered muscle tissues to be used as actuators for force production and 
locomotion of robotic devices in vitro, they must be readily controllable via external signaling. 
The studies outlined in the previous sections primarily utilize electrical signals to drive 
contractility of both cardiac and skeletal muscle tissues. While this is certainly an effective 
signaling method, electrical signaling is disadvantageous in that it cannot be used to precisely 
target precise regions of tissues.  
Optogenetic technology has recently garnered much interest as a method of achieving 
targeted control over cellular behavior. This technology is based on incorporating genes that 
code for light-sensitive ion channels, such as Channelrhodopsin-2, into cellular membranes. This 
renders it possible to control membrane voltage potential via optical signaling, thereby providing 
a noninvasive method of externally triggering the generation of action potentials in muscle tissue  
(Deisseroth 2011). By contrast with electrical signaling, optogenetic signaling allows for highly 
precise spatiotemporal control of stimulation.  
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Light-sensitive ion channels incorporated into cardiac and skeletal muscle tissues are just 
beginning to be explored for application in bioactuation. A recent study of skeletal muscle tissue 
formed in fibrin gels, as in the studies previously considered, utilized myoblasts from the C2C12 
cell line that had been transfected with Channelrhodopsin-2, an ion-channel that is sensitive to 
blue light of 490 nm wavelength. The 3D tissues formed in this study were anchored by 
microfabricated cantilever posts and stimulated to contract via pulsed blue light. The resulting 
deflection of the posts in response to the active tension generated by the muscle was measured 
and converted into a value of force (Figure 2.10) (Sakar 2012). Following these preliminary 
studies, other experiments have demonstrated precision of the optogenetic targeting method and 
its ability to convert light energy into mechanical actuation via wireless and non-invasive 
external signaling (Neal 2013).   
 
Figure 2.10: C2C12 muscle cells transfected with light-sensitive ion channels and seeded 
in a fibrin gel remodel into a 3D strip of engineered muscle over time that mimics the 
morphological and functional behavior of native muscle tissue. Deflection of the cantilever posts 
to which the muscle is anchored yields a quantitative characterization of force generation in 
response to optical and electrical stimulation (Sakar 2012). 
 
 Forward-engineered biological systems require the integration of multiple cell types in 
order to perform complex sensing and actuation tasks. For example, in vivo, muscles are 
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controlled via complex neural circuits that interface with muscle via neuromuscular junctions. 
Efforts to engineer a functional neuromuscular junction in vitro have very recently met with 
success. In a recent study, researchers differentiated mouse neural stem cells into functional 
motor neurons that formed synaptic connections with engineered skeletal muscle. Glutamic acid 
activation of the neurons triggered active potentials and subsequent contractions in the muscle 
(Morimoto et al).  
In similar efforts to integrate multiple cell types into engineered systems, many research 
groups have explored integrating perfusable vascular networks into engineered tissue to mimic 
the complex transport mechanisms seen in vivo. Pioneering studies in this field have 
demonstrated long-lasting perfusable blood vessels that remain stable and functional when 
implanted in vivo (Koike 2004). Studies of microfabricated perfusable vascular networks via 
techniques that are compatible with a variety of cell types and synthetic and natural extracellular 
matrices have also met with success (Miller 2012). However, demonstrations of truly integrated 
biological systems composed of multiple cell types are in a very nascent stage of development.  
It is likely that future studies in this field will rely on differentiation of pluripotent stem 
cells into multiple lineages to form truly integrated cellular systems capable of complex 
functional behaviors. Studies of differentiating stem cells into multiple lineages have recently 
garnered much momentum, leading to the development of “organoids” with morphological 
organization that mimics native tissue (Bershetyn 2013). Application of these technologies to 
create cardiac muscle based bioactuators have been demonstrated (Thavandiran 2013), and future 
research on biological machines and systems will likely use these approaches as enabling tools in 
the fabrication of integrated multi-cellular systems. 
The goal of engineering functional tissues that can sense, process, and respond to signals 
while maintaining metabolic function over long periods of time comes with many diverse 
challenges. While great advances have been made in engineered functional bioactuators that can 
be precisely controlled and interfaced with multiple cell types, there are many technological 
hurdles that must be overcome in order to create systems that can self-organize, self-heal, and 
even self-replicate in response to complex external cues. Stereolithographic microfabrication has 
been proposed as a method for engineering 3D cell culture systems in vitro. The use of this 
technology as an enabling tool in engineering biological machines and systems shall be 
illustrated in this thesis. 
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CHAPTER 3: 3D MICRO-STEREOLITHOGRAPHIC PRINTING 
 
3.1 INTRODUCTION 
Cells in vivo are arranged in precise three-dimensional architectures and surrounded by a 
range of biochemical and mechanical signals that promote cell-cell and cell-matrix interactions 
and control functional behavior. In order to gain a quantitative understanding of the way cells 
sense, process, and respond to signals in their environment, we need to develop in vitro model 
systems that can accurately replicate the structure and function of native tissue. These model 
systems could have a range of applications including high throughput drug testing, tissue 
engineering and regenerative medicine, fundamental studies of disease development, and the 
fabrication of biological machines and systems. 
Engineering in vitro model systems that recreate the structure and function of native 
tissue requires the ability to pattern cells and cell signals at physiologically relevant length 
scales. This motivates the development of a 3D printing apparatus capable of patterning cells and 
cell signals at high resolution, on the order of single cells (1-50 µm). While there have been 
many demonstrations of using a stereolithography apparatus to pattern cells encapsulated in 
highly absorbent hydrogel photopolymers, few have been able to fabricate complex three-
dimensional structures at resolutions on the order of cells in the body (Soman 2013).  
 In this study, a custom-built projection micro-stereolithography apparatus was used to 
pattern hydrogel polymers at resolution < 10 µm. Hydrogels were patterned into 3D structures in 
which distinct layers demonstrated the multi-material patterning abilities of this apparatus. Long-
term viability of NIH/3T3 fibroblast and C2C12 murine myoblast cells encapsulated in these 
patterned hydrogels was evaluated over a period of 7 days.  
 
3.2 MATERIALS AND METHODS 
 
3.2.1 PROJECTION MICRO-STEREOLITHOGRAPHY APPARATUS 
A projection micro-stereolithography apparatus (µSLA) for high-resolution patterning 
was designed and custom-built for this study (Figure 3.1). In this apparatus, broad-spectrum light 
from a lamp (X-Cite 120Q, Lumen Dynamics, Mississauga, Ontario, Canada) is channeled 
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through a liquid-filled light guide and filtered through a collimating adaptor (Zeiss Axio 
Standard, BioVision Technologies, Exton, PA, USA). The resulting collimated light is filtered 
through a UV-passing colored glass filter (UG11, Thor Labs, Newton, NJ, USA) and focused 
through a UV-coated lens (LA1256-A, Thor Labs, Newton, NJ, USA). The light is then filtered 
through two polarizers onto a spatial light modulator (SLM) isolated from a DLP-based projector 
(PowerLite S5, Epson, Suwa, Japan). The filtered light is collected and focused through another 
UV-coated lens (LA1301-A, Thor Labs, Newton, NJ, USA) onto a UV-enhanced aluminum 
turning mirror (CM1-F01, Thor Labs, Newton, NJ, USA) placed within a microscope (Epiphot 
200, Nikon, Tokyo, Japan). Finally, the light is further focused through a 10X microscope 
objective onto the polymerization stage of the µSLA.  
A custom-made micrometer stage capable of 10 µm x-y-z resolution was built by 
combining standard stage apparatus (Mitutoyo, Kawasaki, Japan) and placed above the stage of 
the µSLA polymerization stage. This micrometer stage allowed for rasterizing the projected light 
pattern, giving the ability to create large millimeter scale structures with feature sizes on the 
order of single microns. Patterns for the SLM, which served as the dynamic “mask” for 
polymerization, were generated using gray-scale PowerPoint images (Microsoft, Redmond, WA, 
USA). 
 
Figure 3.1: Schematic of projection micro-stereolithography apparatus 
	  
	   24	  
3.2.2 PRE-POLYMER PREPARATION 
 Poly(ethylene glycol) diacrylate (PEGDA) hydrogels of molecular weight 700 g mol-1 
and 1000 g mol-1 (Sigma-Aldrich, St Louis, MO, USA) were patterned using the µSLA in this 
study. For studies of resolution without encapsulated cells, 20% (v/v) solutions of PEGDA 700 
and 20% (w/v) solutions of PEGDA 1000 were prepared by dissolving the polymer in phosphate 
buffered saline (Lonza, Basel, Switzerland). A 50% (w/v) stock solution of photoinitiator was 
prepared by dissolving 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-one 
(Irgacure 2959, Ciba, Tarrytown, NY, USA) in dimethyl sulfoxide (DMSO, Fisher Scientific, 
Springfield, NJ, USA). This solution was added to the pre-polymer solution to form 0.5% (w/v) 
of photoinitiator for PEGDA 700 and 1.0% (w/v) for PEGDA 1000. Rhodamine-B fluorescent 
dye (R6626, Sigma Aldrich, St Louis, MO, USA) was added to the pre-polymer solutions for 
better visualization of small feature sizes. Cured hydrogels were allowed to swell for at least 1 
hour in phosphate buffered saline (Lonza, Basel, Switzerland) prior to imaging and resolution 
characterization. 
For studies of resolution with encapsulated cells, a 20% (w/v) solution of PEGDA 1000 
was prepared by dissolving the polymer in Dulbecco’s Modification of Eagle Medium (DMEM) 
with or without cells and with L-glutamine and sodium pyruvate without phenol red (Cellgro 
Mediatech, Herndon, VA, USA). The media contained 10% fetal bovine serum (FBS, Sigma 
Aldrich, St Louis, MO, USA), 1% penicillin-streptomycin and 1% L-glutamine (Cellgro 
Mediatech, Herndon, VA, USA). The photoinitator stock solution was added to the pre-polymer 
solution to form 1.0% (w/v) of photoinitiator. 
 
3.2.3 ENERGY DOSE CHARACTERIZATION 
Fluorescent microbeads of 0.4-0.6 µm diameter (Nile Red Beads, Spherotech, Lake 
Forest, IL, USA) were combined with hydrogel pre-polymer solution at a 1:200 volumetric ratio. 
Ultraviolet (UV) light was projected through a blank SLM screen to cure the hydrogel onto a 
glass slide attached to the polymerization stage. The UV light energy was measured using a 
digital power meter calibrated for 325-365 nm (FieldMate, Coherent, Santa Clara, CA, USA). 
The thickness of the cured hydrogel at different values of UV energy dose was measured using 
an inverted fluorescence microscope (IX81, Olympus, Center Valley, PA, USA) and IPLab 
software (BD Biosciences, Rockville, MD, USA). The measured thickness as a function of UV 
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energy dose was plotted on a semi-logarithmic graph and a linear regression analysis was used to 
characterize the relationship between energy dose and thickness. 
 
3.2.4 3D PATTERNING 
The polymerization stage of the µSLA apparatus was rendered hydrophobic by the 
application of Rain-X (Royal Dutch Shell, The Hague, Netherlands). Methacrylated surfaces 
were prepared via treatment of cover glass slides with 0.2% (v/v) 3-(trimethoxysilyl)propyl 
methacrylate (3-TPM, Sigma-Aldrich, St Louis, MO, USA) followed by a wash in 100% ethanol 
(Decon Labs, King of Prussia, PA, USA) and hard-baked on a hot plate at 110ºC. The 
methacrylated cover glass slides were attached to the micrometer stage. The hydrogel 
prepolymer solution was pipetted into the space between the polymerization stage and the 
methacrylated micrometer stage. Once the hydrogel was patterned and cured by the projected 
ultraviolet light, the micrometer stage was moved up in preparation for polymerization of the 
next layer. The polymerized hydrogel was chemically bonded to the methacrylated glass slide 
attached to the micrometer stage and hence did not adhere to the hydrophobic polymerization 
stage during processing. This method was used for layer-by-layer multi-material fabrication of 
3D hydrogel structures. 
 
3.2.5 CELL ENCAPSULATION AND VIABILITY ASSESSMENT 
 NIH/3T3 fibroblasts and C2C12 murine myoblasts were maintained in growth medium: 
DMEM with 10% fetal bovine serum (FBS, Sigma Aldrich, St Louis, MO, USA), 1% penicillin-
streptomycin and 1% L-glutamine (Cellgro Mediatech, Herndon, VA, USA) in an incubator at 
37ºC and 5% CO2. Cells were trypsinized (TrypLE Express, Gibco, Carlsbad, CA) and 
resuspended at a concentration of 5E6 cells mL-1 in PEGDA 1000 pre-polymer solution 
formulated as described in a previous section. Immediately after preparation of the pre-polymer 
solution, the cells were patterned using the µSLA apparatus and placed in warm growth medium 
and incubated at 37ºC and 5% CO2.  
 Viability was assessed via MTS colorimetric assay, in which a reaction between MTS (3-
(4,5-dimethylthiazol-2-yl)-5-(3- carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, 
Promega, Madison, WI, USA) and phenazine methosulfate (PMS, Sigma Aldrich, St Louis, MO, 
USA) produces a water-soluble purple formazan product as an indication of the presence of 
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living cells. An assay solution of MTS at a concentration of 333 µg mL−1 and 25 µM PMS 
dissolved in DMEM without phenol red was added to wells containing hydrogels with 
encapsulated cells patterned by the µSLA apparatus. The hydrogels were incubated in this assay 
solution for a period of 4 hours at 37ºC and 5% CO2. After the incubation period, the assay 
solution was removed from the wells and pipetted into a separate well plate. Absorbance of the 
assay solution was measured at 490 nm using a microplate reader (BioTek, Winooski, VT, 




3.3.1 RESOLUTION CHARACTERIZATION OF PATTERNED HYDROGELS 
 The ultimate goal of building a projection micro-stereolithography apparatus is to 
microfabricate large millimeter-scale hydrogel structures with feature sizes on the order of single 
microns. In order to attain this high resolution, the energy dose of ultraviolet light required to 
cure the hydrogel pre-polymer solution must be precisely determined. Under-curing structures 
will result in low-fidelity polymers without resolved features that will disintegrate quickly. Over-
curing structures will result in high-density cross-linking and swelling of the hydrogels that will 
overwrite existing small features.  
 To determine the optimal energy dose of ultraviolet light required to cure hydrogels with 
small feature sizes, it is necessary to characterize the relationship between ultraviolet energy 
dose and the thickness, or “cure depth”, of the polymerized hydrogels. In this study, fluorescent 
micro-beads were encapsulated in the hydrogels and a fluorescence microscope was used to 
measure the thickness of polymerized parts, as described in Section 3.2.3. Thickness of poly 
(ethylene glycol) (PEGDA) polymers of molecular weight 700 g mol-1 and 1000 g mol-1 was 
plotted as a function of ultraviolet energy dose on a semi-logarithmic graph (Figure 3.2). A linear 
regression analysis was used to develop a characteristic equation for the µSLA apparatus. The R2 
values of 98.3% for PEGDA 700 and 97.3% for PEGDA 1000 indicate a strong correlation 
between the characteristic equation and the data generated by the µSLA apparatus.  
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Figure 3.2: Characterization of cure depth as a function of ultraviolet energy dose 
 
Dispersion of projected light through the pre-polymer solution results in an increase in 
the resolved feature size as the light penetrates further into the solution (Figure 3.3). Therefore, 
in order to preserve the small feature size patterning capabilities of the µSLA apparatus, a 
prescribed thickness of 50 µm was used for all x-y resolution characterization experiments. An 
increase in thickness will result in a corresponding increase in feature size. 
 
 
Figure 3.3: Resolved feature size decreases with increased penetration depth into pre-
polymer solution, demonstrating the need for thickness control in the µSLA 
  
Resolution characterization experiments of the smallest lines and holes that can be 
fabricated using the µSLA apparatus were conducted using PEGDA hydrogel polymers of 
molecular weight 700 g mol-1 and 1000 g mol-1. Images of lines, holes, text, and other patterns 
were created using PowerPoint software and sent to the spatial light modulator (SLM), which 
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acted as a dynamic mask for polymerization, as described in Section 3.2.1. The shorter polymer 
chains in PEGDA 700 reduced swelling of the cured hydrogels, thereby resulting in higher 
resolution features (~ 2.5 µm) as compared to PEGDA 1000 hydrogels (~ 5 µm) (Figure 3.4).  
 
Figure 3.4: A) Demonstration of resolution with PEGDA 700 with dynamic SLM mask; 
B) Demonstration of resolution with PEGDA 1000 with dynamic SLM mask (50µm hydrogel 
thickness). Both PEGDA 700 and 1000 hydrogel polymers were mixed with Rhodamine B 
fluorescent dye prior to polymerization. Dark regions in fluorescent images indicate no polymer 
present, verifying that the high-resolution patterns are present throughout the gel thickness.  
 
3.3.2 FABRICATION OF 3D HYDROGEL STRUCTURES 
 Characterization of cure depth as a function of energy dose is useful for resolution 
studies, but is also an important factor in fabricating 3D hydrogel structures. The µSLA 
apparatus builds 3D structures through sequential layer-by-layer patterning of 2D cross-sections 
of a 3D design. In order for each new polymerized layer to bond to the previous layer, the 
ultraviolet light energy used to polymerize the current layer needs to penetrate into the previous 
layer, forming polymer chain cross-links between them. However, over-exposure of the previous 
layer to ultraviolet energy will result in over-curing of that layer, which has negative 
implications on the corresponding resolution that can be attained.  
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 In this study, the first step in fabricating 3D hydrogel designs was determining the 
thickness of each layer of the structure. Using the characteristic equation of the µSLA apparatus, 
this thickness was translated into an appropriate energy dose. 2D cross-sections of a 3D design 
were created using PowerPoint software and sent to the spatial light modulator (SLM) 
sequentially, with the bottom-most layer appearing first. The first layer was chemically bonded 
to the micrometer stage via methacrylation and each subsequent layer bonded to the previous 
layer by the slight and well-characterized over-curing described previously.  
PEGDA with different fluorescent markers was used to simulate fabrication with multiple 
materials (Figure 3.5). After polymerization of the first layer of the 3D structure, the remaining 
pre-polymer solution was washed away and replaced with a different pre-polymer solution to be 
used for the second layer. This demonstration of multi-material fabrication of structures is an 




Figure 3.5: Fluorescence imaging of PEGDA 1000 hydrogel structures with and without 
Rhodamine B dye demonstrates the ability of the µSLA apparatus to fabricate multi-material 3D 
hydrogel structures, such as the hollow micro-channel shown here. 
 
3.3.3 CELL ENCAPSULATION AND VIABILITY 
 Encapsulating cells inside hydrogels using the µSLA apparatus introduces another 
component into the pre-polymer solution that causes dispersion of light, resulting in a reduced 
ability to resolve very small features. Furthermore, encapsulation of cells comes with the 
additional challenge of regulating light exposure. Over-exposure to ultraviolet light can damage 
and reduce the viability of cells encapsulated in the patterned hydrogels. While increasing the 
photoinitiator concentration can decrease the energy dose required to polymerize the hydrogels, 
the photoinitiator itself is cytotoxic in large doses and can reduce viability in the long term 
(Bryant 2012). 
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In this study, either NIH/3T3 fibroblasts or C2C12 murine myoblasts were suspended in 
PEGDA 1000 pre-polymer solution with 1.0% (w/v) photoinitiator (formulation described in 
Section 3.2.2) at concentrations ranging from 5E6 cells mL-1 to 20E6 cells mL-1. Demonstration 
of feature sizes on the order of single cells was demonstrated using this pre-polymer formulation. 
MTS colorimetric assay was used to quantitatively assess for viability of encapsulated cells, as 
described in Section 3.2.5. Experiments showed that viability of encapsulated cells decreased 
with increasing energy dose (Figure 3.6). In long-term studies assessing viability at several time 
points, encapsulated cells were shown to remain viable within the hydrogel polymer matrix over 
a period of 7 days.  
 
 
Figure 3.6: A) MTS Staining showing live C2C12 myoblasts encapsulated in PEGDA 1000 
hydrogels with small-scale feature sizes (100 µm Thickness). Dark color post-MTS assay 
indicates the presence of living cells; B) Viability assessed via MTS for NIH/3T3 fibroblasts 72 
hours after encapsulation in PEGDA 1000 hydrogels. Viability of encapsulated cells decreases 
with increasing energy dose. 
 
3.4 DISCUSSION 
 The goal of building in vitro model biological systems for applications in programmable 
tissue engineering and the design of biological machines cannot be accomplished without 
enabling microfabrication technologies that allow for high resolution patterning of biomaterials, 
cells, and cell signals in three dimensions. The projection micro-stereolithography apparatus 
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presented in this study is capable of viably encapsulating cells in absorbent hydrogel polymers 
and patterning these structures at very high resolution.  
As compared to other physical mask based polymerization apparatus, the dynamic mask 
technology enabled by the spatial light modulator in the µSLA allows for great flexibility in the 
design and fabrication of any 3D structure. Instead of directly tracing a design by rasterizing a 
laser, as is conventional in many existing stereolithographic bio-fabrication apparatus, the µSLA 
can polymerize whole patterns in one projection, without the need for rasterizing. This allows for 
high-throughput fabrication of large-scale structures with small feature sizes. While there have 
been other dynamic mask based projection stereolithography apparatus presented in the 
literature, these largely rely on digital micro-mirror devices (DMD) to act as dynamic masks for 
polymerization. These masks are limited in their ability to reproduce only black and white 
images, resulting in an “on” or “off” state for each pixel of the projected image (Sun 2005). By 
contrast, the use of a spatial light modulator (SLM) allows for projection of gray-scale images, 
allowing for smooth gradations of ultraviolet light energy projected onto the pre-polymer 
solution. This is anticipated to prove particularly advantageous for the fabrication of smoothly 
graded structures such as domes and spheres.  
 In this µSLA apparatus, the bottom layer is fabricated first and each subsequent layer is 
sequentially patterned and bonded to the previous layer to form the 3D structure. This bottoms-
up “upside down” fabrication approach is novel and, in general, different from other projection 
stereolithography apparatus presented in the literature (Sun 2005, Zhang 2012). One advantage 
of this approach of fabricating parts is that it accommodates for cell-settling effects. In “right 
side up” approaches, prepolymer solution is dispensed on top of a fabricated layer prior to 
polymerization and cells start settling immediately. These systems are thus very sensitive to the 
time taken to polymerize parts and an even and controllable distribution of cells within the 3D 
structures is very difficult to accomplish. In the upside down approach, cells and prepolymer are 
directly dispensed into the prescribed volume of space between the polymerization stage and the 
micrometer stage immediately before hydrogel curing. This ensures that the cells are in fact 
evenly distributed throughout the multiple layers of the part. An additional advantage of the 
upside down approach for fabrication is that it readily enables incorporation of a 
dielectrophoresis (DEP) based cell patterning approach into the µSLA. Briefly, when electrodes 
are integrated with the polymerization stage of the apparatus and an electric field is generated, 
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cells align along the electrodes and can be aligned and patterned with high fidelity. While 
conventional approaches for incorporating DEP have only been able to pattern single layers of 
cells in hydrogels (Bajaj 2011), this upside down approach ensures that cells can be separately 
aligned and patterned in each layer. This also ensures that cells aren’t exposed to the same fields 
multiple times, thereby increasing the viability of cells undergoing the encapsulation process. 
This integrated DEP system for highly precise and controllable patterning of cells is the future of 
this µSLA apparatus and shall be further discussed in Chapter 5. 
 
3.5 CONCLUSION 
 A projection micro-stereolithography apparatus that uses a spatial light modulator as a 
dynamic mask for polymerization was designed and custom built for fabrication of 3D hydrogel 
structures with very small feature sizes, on the order of single cells. The relationship between 
energy dose and cure depth was well characterized and used to sequentially pattern and layer 2D 
cross sections of 3D multi-material designs. Feature size resolution of 2.5µm with PEGDA 700 
and 5µm with PEGDA 1000 was demonstrated, along with the ability to preserve high resolution 
patterning with encapsulated cells in PEGDA 1000. Viability of cells encapsulated in hydrogels 
using the µSLA was quantitatively assessed as a function of ultraviolet energy dose and proven 
viable over a period of 7 days. The µSLA can thus be used to pattern cells and cell signals at high 
resolution for fundamental studies of cell mechanics and cell-matrix interactions. By enabling 
applications in tissue engineering, scaffold generation with living cells, and the development of 
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CHAPTER 4: BIOLOGICAL MACHINES 
 
4.1 INTRODUCTION 
 The emerging field of tissue engineering is centered on building complex biological 
substitutes for native tissue using a combination of cells and instructive biomaterials. While the 
goal of reverse engineering native tissue is promising for medical applications, it is not the only 
field of research opened up by work in this area. If we can rebuild existing systems with cells, we 
can also design novel systems that harness the innate dynamic abilities of cells to self-organize 
and respond to environmental cues. This idea of forward engineering integrated cellular systems 
with multiple functionalities is the core philosophy of engineering biological machines.  
 Perhaps the most intuitive demonstration of a biological machine is one that can generate 
force and produce motion. Cell-based soft robots, or “bio-bots,” that can accomplish such 
objectives of robotics as sensing, storage and processing of signals, and a resultant response such 
as actuation can address many engineering challenges. A bio-bot can, for example, be engineered 
to detect a chemical toxin, achieve net motion towards it, and neutralize the toxin by releasing 
cell-secreted chemicals. This can be used to remove pathogens from water supplies or neutralize 
toxins in vivo. Recent studies have demonstrated bio-bots that use the autonomous and 
synchronous contraction of cardiac muscle cells as actuators for locomotion (Nawroth 2012, 
Chan 2012). While these machines demonstrate the power of using cells as building blocks for 
engineered systems, they are still quite primitive in that they lack the ability to be controlled via 
external signals.  
In this study, a skeletal-muscle based biological machine was engineered and locomotion 
externally controlled via electrical and optical signals. The force production capabilities of these 
machines in the passive and active tension state of the muscle strip were characterized. Modeling 
and simulation of these machines was used to understand the effect of different design 
parameters on the machine, as well as to understand the mechanism of motion. Future 
generations of these microfabricated biological machines, including machines powered via the 
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4.2 MATERIALS AND METHODS 
 
4.2.1 MACRO-STEREOLITHOGRAPHY APPARATUS & PRE-POLYMER PREPARATION 
 A commercial laser-based stereolithography apparatus (SLA, Model 250/50, 3D Systems, 
Rock Hill, SC, USA) was custom-modified for building the bio-bots in this study. The SLA uses 
a HeCd gas laser as a source of 325 nm ultraviolet light. The laser beam is deflected by a set of 
scanning mirrors onto the polymerization stage of the SLA. Controlled scanning of the mirrors 
rasterizes the laser beam across the polymerization stage, allowing the apparatus to trace and 
cure hydrogels in specified 2D patterns at an x-y resolution of 250 µm (Figure 4.1). 
 
 
Figure 4.1: Schematic of laser-based stereolithography apparatus 
 
 3D designs for fabrication were generated using SolidWorks computer-aided design 
software (Dassault Systems, Velizy, France). Designs were converted into standard tessellation 
language (.stl) files and processed using 3DLightyear software (3D Systems, Valencia, CA, 
USA), which sliced the 3D designs into sequential 2D cross-sections. These cross-sections were 
processed by the SLA computer system and parts were fabricated layer-by-layer from the bottom 
up. Fabrication of 3D bio-bot and holder structures is detailed in Section 4.2.2. 
 Poly (ethylene glycol) diacrylate (PEGDA) hydrogels of molecular weight 700 g mol-1 
and 1000 g mol-1 (Sigma-Aldrich, St Louis, MO, USA) were used to fabricate the bio-bots in this 
study. Prepolymer solutions of 20% (v/v) PEGDA 700 and 20% (w/v) PEGDA 1000 each with 
0.5% (w/v) photoinitiator concentration were formulated as described in Section 3.2.2.  
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4.2.2 FABRICATION AND PROCESSING OF HYDROGEL BIO-BOT STRUCTURES 
 The 3D hydrogel bio-bot structure consists of two capped pillars connected by a flexible 
beam (Figure 4.2). The structure was fabricated as follows: First, a 18 mm square glass coverslip 
was taped to a 35 mm diameter dish and treated with oxygen plasma to render the surfaces 
hydrophilic. 1200 uL of PEGDA 700 prepolymer solution was pipetted onto the coverslip and 
the first layer of the bio-bot, the beam, was polymerized. Following this, the pillars and caps 




Figure 4.2: A) Symmetric bio-bot design; B) Asymmetric bio-bot design 
 
 To aid in the process of forming muscle strips, hydrogel holders for the bio-bot structures 
were fabricated using the SLA (Figure 4.3). The structure was fabricated as follows: First, an 18 
mm square glass coverslip was methacrylated using the protocol detailed in Section 3.2.4 and 
taped to a hydrophilic dish. 1200 uL of PEGDA 1000 prepolymer solution was pipetted onto the 
coverslip and the first layer of the holder was polymerized, to correspond with the thickness of 
the first layer of the bio-bot beam. Following this, the walls of the holder were fabricated in 200 
µm thick layers with 250 uL of PEGDA 1000 prepolymer solution per layer. 
 Immediately after fabrication, the hydrogel structures were washed in phosphate buffered 
saline (PBS, Lonza, Basel, Switzerland), sterilized in 70% ethanol (Decon Labs, King of Prussia, 
PA, USA) for 45 minutes, and stored in PBS at 4ºC until ready for cell seeding and muscle strip 
formation. 
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Figure 4.3: A) Holder design B) Holder and symmetric bio-bot final assembly. 
 
4.2.3 MECHANICAL TESTING 
 Mechanical properties of the fabricated hydrogel structures were required for extraction 
of muscle force data as well as modeling and simulations. For this study, dogbone shaped tensile 
test specimens of the same material and thickness as the beam of the bio-bot were fabricated 
using the SLA. Beams of different stiffness were obtained by varying the ultraviolet energy dose 
of the SLA from 108.7 – 512.6 mJ cm-2. Uniaxial tension was applied to the test specimens using 
a tensile test apparatus (ElectroForce Biodynamic 5100, Bose, Framingham, MA, USA) at a 
strain rate of 0.05 mm s-1. Samples were maintained in an air-tight chamber filled with phosphate 
buffered saline throughout the testing process. A video extensometer was used to track the 
displacement of four marked points in the gauge section of the test specimen and control 
software was used to track the force exerted by the 100 g load cell and the corresponding strain 
in the specimen. Stress was computed by dividing the exerted force by the cross-sectional area of 
the specimen, as measured manually via calipers. Hooke’s Law was used to compute the elastic 
modulus of the material from the linear region of the stress-strain curve.   
 
4.2.4 CELL CULTURE  
 C2C12 murine myoblasts transfected with pAAV-Cag-Chr2-GFP-2A-Puro plasmin to 
express a light-sensitive ion channel, channel rhodopsin (ChR2), were used for the skeletal 
muscle bio-bots in this study (Sakar 2012). These cells were a gift from Professor Harry Asada at 
MIT. ChR2 C2C12s were maintained in growth medium: DMEM with 10% fetal bovine serum 
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(FBS, Sigma Aldrich, St Louis, MO, USA), 1% penicillin-streptomycin and 1% L-glutamine 
(Cellgro Mediatech, Herndon, VA, USA) in an incubator at 37ºC and 5% CO2. Cells were 
regularly passaged 1:10 when they reached 70-80% confluency.  
 Primary ventricular cardiomyocytes used for cardiac muscle bio-bots in this study were 
isolated from neonatal (1-3 days old) Sprague-Dawley rats (Harlan Laboratories, Indianapolis, 
IN, USA) using a protocol approved by the Institutional Animal Care and Use Committee 
(IACUC Protocol #11160). Whole hearts were excised and placed in cold PBS. The atria and 
blood vessels were removed using small scissors and forceps and the remaining ventricles were 
quartered into 1-2 mm2 pieces. The quartered hearts were digested in 0.05% (w/v) trypsin 
(TrypLE Express, Gibco, Carlsbad, CA, USA) in PBS for 16-18 hours on a shaker at 4°C. 
Trypsin digestion was halted by adding growth medium and the tissue fragments were 
transferred to a solution of 0.2% (w/v) type II collagenase in PBS for 45 minutes while shaking 
at 37°C. Mechanical trituration was used to release cells from the tissue fragments following 
collagenase incubation and the cell suspension was filtered through a 70 µm cell strainer (BD 
Biosciences, Franklin Lakes, NJ, USA) to remove undigested tissue. The filtered suspension was 
centrifuged at 750 rpm for 4 minutes and resuspended in growth medium. Cells were preplated in 
a tissue culture flask for one hour to enrich for cardiomyocytes and then either seeded in muscle 
strips or plated. Plated cells were maintained in growth medium: DMEM with 10% fetal bovine 
serum (FBS, Sigma Aldrich, St Louis, MO, USA), 1% penicillin-streptomycin and 1% L-
glutamine (Cellgro Mediatech, Herndon, VA, USA) in an incubator at 37ºC and 5% CO2. 
 HEK293 human embryonic kidney cells used for the cardiac muscle bio-bots in this study 
were transfected with pAAV-Cag-Chr2-GFP-2A-Puro plasmin to express a light-sensitive ion 
channel, channel rhodopsin (ChR2). HEK 293 cells were maintained in growth medium: DMEM 
with 10% fetal bovine serum (FBS, Sigma Aldrich, St Louis, MO, USA), 1% penicillin-
streptomycin and 1% L-glutamine (Cellgro Mediatech, Herndon, VA, USA) in an incubator at 
37ºC and 5% CO2. Cells were regularly passaged 1:10 when they reached 70-80% confluency.  
 
4.2.5 FORMATION OF 3D MUSCLE STRIPS 
 To form the 3D muscle strips, the bio-bot hydrogel structures were placed in the holders. 
Cells were suspended in a gel solution of synthetic extracellular matrix and the solution was 
pipetted into the well of the holder. Over time, the traction forces exerted by the cells caused the 
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cell/gel solution to compact into a 3D muscle strip capable of contractility and force generation 
Muscle strips formed by cells seeded in a synthetic extracellular matrix composed of either fibrin 
or collagen were used in this study. 
Formulation of fibrin cell/gel matrix solution: Cells were suspended in room temperature 
growth medium at a concentration of 5-10 E6 cells mL-1. A stock 0.5U/mg solution of thrombin 
from bovine plasma (Sigma Aldrich, St Louis, MO, USA) was added to the cell suspension to 
make a 0.5% (v/v) concentration of the final cell/gel matrix solution. Matrigel basement 
membrane matrix (BD Biosciences, Franklin Lakes, NJ, USA) at 4ºC was added to the cell 
suspension at a concentration of 30% (v/v) of the final matrix solution. Finally, a 4mg/mL stock 
solution of fibrinogen (Sigma Aldrich, St Louis, MO, USA) at 4ºC was added to the cell 
suspension at a concentration of 50% (v/v) of the final matrix solution. The final cell/gel solution 
was pipetted into the well of a holder/bio-bot assembly and allowed to set at 37ºC for 45 minutes 
before the addition of warm growth medium.  
Formulation of collagen cell/gel solution in room temperature growth medium at a 
concentration of 5-10 E6 cells mL-1. Matrigel basement membrane matrix (BD Biosciences, 
Franklin Lakes, NJ, USA) at 4ºC was added to the cell suspension at a concentration of 10% 
(v/v) of the final matrix solution. A solution of collagen type I at 4ºC (BD Biosciences, Franklin 
Lakes, NJ, USA) was mixed with growth medium at a 1:1 volumetric ratio, forming a 76% (v/v) 
concentration of the final matrix solution. A solution of 0.1 M NaOH (Sigma Aldrich, St Louis, 
MO, USA) was added to this solution to form a 10% (v/v) concentration of final matrix solution. 
These two solutions were combined and seeded into the well of a holder/bio-bot assembly and 
allowed to set at 37ºC for 75 minutes before the addition of warm growth medium.  
Both fibrin and collagen matrix bio-bots were preserved in an incubator at 37ºC and 5% 
CO2 and media was replaced every 24 hours. The bio-bot structures deformed in response to the 
formation of the muscle strip and were removed from the holders on the second day. Cardiac 
bio-bots were maintained in growth medium throughout the study period. Skeletal muscle bio-
bots were maintained in differentiation medium after the first day. This medium consisted of 
DMEM with 10% horse serum (Lonza, Basel, Switzerland), 1% penicillin-streptomycin, 1% L-
glutamine (Cellgro Mediatech, Herndon, VA, USA), either 0 or 50 ng/mL human insultin-like 
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growth factor-1 (IGF-1, Sigma-Aldrich, St Louis, MO, USA) and either 1 or 2 mg/mL anti-
fibrinolytic 6-aminocaproic acid (ACA, Sigma-Aldrich, St Louis, MO, USA).* 
 
4.2.6 ELECTRICAL STIMULATION 
 Contractility of bio-bot muscle strips was triggered via electrical stimulation using a 
custom built apparatus (Bajaj 2011) (Figure 4.4). Prior to stimulation, bio-bots were transferred 
to a dish containing serum-free medium. The beam of the bio-bot lay parallel to a pair of 
platinum electrodes connected to the stimulation apparatus. Electrical square-wave signals of 
20V amplitude and 50ms pulse width of frequencies from 1-3Hz were conveyed through the 
electrodes, driving contraction of the engineered muscle. Videos of stimulation were acquired 
with a digital microscope camera (FLEX, SPOT Imaging, Sterling Heights, Michigan, USA) at 
10 fps.  
 
Figure 4.4: Schematic of electrical stimulation apparatus used to pace bio-bots. 
 
4.2.7 OPTICAL STIMULATION 
Contractility of bio-bot muscle trips was triggered via optical stimulation using an LED 
emitting blue light at a wavelength of 490 nm. The LED was connected to a function generator 
and square-wave signals of 10V amplitude and 100-200ms pulse width of frequencies from 1-
3Hz were used to drive optically stimulated contraction of the engineered muscle. Top-view 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
*	  The	  bio-­‐bot	  muscle	  strips	  characterized	  in	  the	  electrical	  pacing	  studies	  were	  fabricated	  
and	  imaged	  by	  Caroline	  Cvetkovic,	  a	  student	  in	  Dr.	  Rashid	  Bashir’s	  research	  group	  at	  the	  
Univeristy	  of	  Illinois	  at	  Urbana-­‐Champaign.	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videos of stimulation were acquired using an inverted microscope (IX81, Olympus, Center 
Valley, PA, USA) and CCD camera (RT3, SPOT Imaging, Sterling Heights, Michigan, USA) at 
12fps. Side-view videos of stimulation were acquired using a camcorder (Handycam DCR-SR65, 
Sony, Tokyo, Japan) at 30 fps. 
 
4.2.8 TISSUE FIXATION 
 Bio-bot muscle strips were fixed in 4% formaldehyde (CAT RT 15710, EMS, Hatfield, 
PA, USA) for 30 minutes, washed in phosphate buffered saline (PBS, Lonza, Basel, Switzerland) 
for 15 minutes, and permeabilized in 0.2% (v/v) Triton X-100 in PBS (Sigma Aldrich, St Louis, 
MO, USA). Following this step, muscle strips were washed in PBS for fifteen minutes and 
preserved in signal Fx enhancer (I36933-IT, Invitrogen, Carlsbad, CA, USA) at 4ºC in 




4.3.1 PASSIVE TENSION GENERATED BY ENGINEERED SKELETAL MUSCLE 
 Cells encapsulated in a synthetic extracellular matrix composed of fibrin exerted traction forces 
that compacted the cell/gel matrix solution over time into a 3D strip of engineered muscle. As the strip 
formed around the compliant microfabricated hydrogel structure, the two pillars of the bio-bot served as 
anchors for the muscle strip (Figure 4.5). The beam of the bio-bot underwent a change in conformation in 
response to the passive tension force generated by the engineered muscle. Since tensile force production 
is an important characteristic of the performance of engineered muscle, characterizing this force was a 
first step in assessing the functional behavior of these engineered bioactuators. 
 
Figure 4.5: Cells seeded in a fibrin gel matrix exert traction forces to compact into an 
engineered muscle strip around 3D printed hydrogel bio-bot structure. 
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 In this study, PEGDA 700 hydrogel bio-bot beams were polymerized using the SLA apparatus 
with ultraviolet light energy doses varying from 108.7 – 512.6 mJ cm-2. Hydrogel test specimens 
were loaded in a tensile test apparatus and force-displacement data was recovered as described in 
Section 4.2.3. Since these hydrogels behave as linear elastic materials at low strain rates (Anseth 
1996, Kloxin 2010), the elastic modulus was readily retrieved from the linear portion of the 
stress-strain curve as described by Hooke’s Law, . Modulus of beams increased with 
increasing ultraviolet energy dose and varied from 214.6 – 741.6 kPa (n = 5, Figure 4.6). 
 
Figure 4.6: Modulus of polymerized hydrogels as a function of ultraviolet energy dose of SLA 
laser beam. A logarithmic fit provides an accurate description of this relationship.  
 
Fibrin matrix muscle strips with skeletal muscle cells encapsulated at a concentration of 
5E6 cells mL-1 were cultured in differentiation medium containing 50 ng/mL of human insulin-
like growth factor, IGF-1, and 1 mg/mL of anti-fibrinolytic aminocaproic acid, ACA. Muscle 
strips were imaged over a period of nine days to observe the evolution of muscle strip formation 
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as a function of time and beam modulus. The maximum deflection of the center of the beam 
along with the distance of the muscle strip centroid from the beam was measured and recorded 
using ImageJ image analysis software (National Institutes of Health). As per Euler-Bernoulli 
beam theory, the	  differential	  equation	  that	  relates	  the	  deflection	  of	  a	  curved	  beam	  to	  the	  




In this equation, P is the passive tension generated by the muscle strip, y is the transverse 
deflection of the beam, l is the distance between the muscle strip and the beam (effectively the 
moment arm of the force), E is the elastic modulus of the deformed beam, and I is the moment of 
inertia of the beam. 
Under the assumptions of small strain and small rotation (i.e. y’ is considered negligible), 
the baseline tension, P, can be recovered as a function of the maximum deflection of the beam, 







Using the known geometric and material properties of the hydrogel beam, as well as the 
measured deflection of the beam and moment arm of the muscle strip, passive tension force was 
recovered for bio-bots with hydrogel beams of varying stiffness. For moduli of 214.6, 319.4, 
411.2, and 489.3 kPa, the passive tension recorded over days 2-9 averaged 860.6 ± 47.2, 992.7 ± 
34.3, 1103.6 ± 45.8, and 1146.0 ± 69.0 µN respectively. There is a positive correlation between 
increasing beam stiffness and increasing passive tension in the muscle (Figure 4.7). 
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Figure 4.7: Passive tension force generated by engineered muscle strip increases for increasing 
bio-bot beam moduli. Passive tension force is dependent on the presence of IGF-1. 
 
To compare the force generated by these muscle strips to other engineered muscle 
systems, the passive stress in the tissue was calculated by dividing tension by the measured 
cross-sectional area of the muscle strips, 1.19 ± 0.04 mm2 as determined by transverse 
histological cross-sections. On average, the passive stress averaged 0.84 ± 0.03 kPa, falling 
within the range of stress values reported in the literature for similar engineered systems of 
different scales, but significantly lower than the force produced by native muscle (260 kPa) (Lam 
2009). 
 Passive tension was studied as a function of various parameters such as concentration of 
IGF-1 in the differentiation medium, concentration of ACA in the differentiation medium, and 
concentration of cells in the cell/gel matrix solution. Fibrin based muscle strips of beam stiffness 
319.4 kPa, with cells encapsulated at 5E6 cells mL-1 and cultured without IGF-1 developed a 
lower passive tension force of 581.4 ± 20.4 µN, on average. This is a 41.4% decrease in force 
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production as compared to the muscle strips cultured with 50ng/mL IGF-1. Similarly, fibrin 
based muscle strips of beam stiffness 319.4 kPa cultured with 2 mg/mL ACA demonstrated an 
11.6% decrease in force production as compared to the muscle strips cultured with 1 mg/mL 
ACA.  
Fibrin matrix muscle strips with skeletal muscle cells encapsulated at a higher cell 
concentration of 10E6 cells mL-1 demonstrated a corresponding increase in passive tension force 
to 1236.18 ± 49.2 µN, a 24.5% increase in tension as compared to the muscle strips with 5E6 
cells mL-1. These dependencies of passive tension force on the cell/matrix composition and 
culture conditions as well as the modulus of the hydrogel bio-bot structure illustrate the dynamic 
modeling capabilities of engineered skeletal muscle. 
To verify the accuracy of the passive tension values extracted using Euler-Bernoulli beam 
theory, the computed force values were input to the bio-bot structure in an ANSYS based finite 
element simulation (ANSYS, Canonsburg, PA, USA). The resulting deflections of the simulated 
beams of stiffness 214.6, 319.4, and 489.3 kPa were 1.24, 1.004, and 0.44 mm respectively 
(Figure 4.8). These values decreased with increasing material stiffness, as expected, since these 
materials offered greater resistance to the bending motion produced by the cell traction forces. 
Simulated deflection values differed by approximately 18%, on average from the experimentally 
measured deflection values on Day 8 of culture, indicating that the linear bending theory model 






























Figure 4.8: Finite Element Analysis of beam deflection as a function of bio-bot beam 
stiffness. Increased stiffness offers a greater resistance to bending and therefore a smaller 
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4.3.2 ACTIVE TENSION GENERATED BY ENGINEERED SKELETAL MUSCLE 
 Stimulation by electrical or optical signals causes contraction of the engineered muscle 
strip. The resulting increase in tension, as compared to the baseline passive tension, is termed the 
active tension generated by the muscle. Treating the hydrogel bio-bot structure as a linear elastic 
material governed by Hooke’s law, as before, the force, F, required to deform the beam by an 
amount dx is given by , where k represents the stiffness of the structure. This stiffness 





The amount of force required to the passive state is the passive tension force, P, calculated via 
Euler-Bernoulli beam theory, as discussed in Section 4.3.2. 
 An automated tracking script written in Matlab (MathWorks, Natick, MA, USA) based 
on a normalized 2D cross-correlation of successive frames in a video was used to extract the time 
varying distance between the two ends of a bio-bot during stimulation-induced contraction†. In 
these videos, the bio-bots were placed in a dish containing warm media and stimulated 
electrically, as described in Section 4.2.6. Knowing the stiffness, k, of the bio-bot structure as 
well as the passive tension force, P, the active tension force, F, generated by the contracting 




 Fibrin matrix muscle strips with skeletal muscle cells encapsulated at a concentration of 
5E6 cells mL-1 cultured in differentiation medium containing 50 ng/mL of IGF-1 and 1 mg/mL 
of ACA were seeded around both “symmetric” and “asymmetric” bio-bot structures, stimulated 
electrically, and paced at frequencies of 1,2, and 4 Hz as described in Section 4.2.6. As the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
†	  Automated	  tracking	  script	  was	  written	  by	  Brian	  Williams,	  a	  graduate	  student	  in	  Professor	  
Taher	  Saif’s	  research	  group	  at	  the	  University	  of	  Illinois	  at	  Urbana-­‐Champaign.	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frequency of stimulation increased from 1 to 4 Hz, the magnitude of active tension forces above 
baseline passive tension decreased from 198.68 µN to 109.48 µN. Above a frequency of 8 Hz, 
tetanus of the muscle strip was observed. Muscle strips cultured in differentiation medium 
without IGF demonstrated no contractile behavior in response to electrical stimulation. 
 
4.3.3 ELECTRICALLY STIMULATED LOCOMOTION OF SKELETAL MUSCLE BIO-BOT 
Demonstration of external control-driven locomotion is the first step toward engineering 
bio-bots with complex functionality. In this experiment, bio-bots were placed in a dish 
containing warm media parallel to the electrodes in the stimulation apparatus and allowed to 
move freely across the surface of the dish. The electrical stimulation driven contraction of the 
muscle strip caused a change in conformation of the hydrogel beam. The resultant flexion caused 
the bio-bots to “crawl” across the substrate, demonstrating net locomotion. 
Both symmetric and asymmetric bio-bots of beam stiffness 319.4 kPa were seeded with a 
fibrin matrix cell/gel solution containing 5E6 cells mL-1 and differentiated in culture medium 
with IGF and ACA. The bio-bots were electrically stimulated 7-13 days after seeding and 
demonstrated a range of velocities ranging from 0.66 – 69.5 µm s-1. An average velocity of 13.4 
± 20.6 µm s-1 for symmetric bio-bots and 28.1 ± 25.2 µm s-1 for asymmetric bio-bots was 
observed‡. 
A representative bio-bot of both the symmetric and asymmetric bio-bot designs was 
chosen for analysis of locomotion in response to electrically paced contraction. Active tension 
was computed and a maximum active tension force of 73.76 µN above baseline passive tension 
for symmetric bio-bots and 787.93 µN above baseline passive tension for asymmetric bio-bots 
was recorded during electrical stimulation (Figure 4.9). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
‡	  Velocity	  for	  electrically	  paced	  skeletal	  muscle	  bio-­‐bots	  was	  calculated	  by	  Caroline	  
Cvetkovic,	  graduate	  student	  in	  Dr.	  Rashid	  Bashir’s	  research	  group	  at	  the	  University	  of	  
Illinois	  at	  Urbana-­‐Champaign.	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Figure 4.9: Active Tension of representative A) symmetric and B) asymmetric bio-bot 
designs paced via electrical stimulation at 1Hz frequency 
 
4.3.4 MECHANISM OF LOCOMOTION OF SKELETAL MUSCLE BIO-BOT 
 Understanding the mechanism of locomotion of the skeletal muscle bio-bot is an 
important step in designing bio-bots with increased efficiency and functionality. A digital model 
of the bio-bot structure in its deformed passive tension state was generated using SolidWorks 
CAD software (Dassault Systems, Velizy, France) and imported into the ANSYS finite element 
package (ANSYS, Canonsburg, PA, USA). In order to recapitulate the walking motion captured 
in videos of electrically stimulated bio-bots, the tracked displacement of the right and left pillars 
of the bio-bot was input to the simulation. The bio-bots were placed on a frictionless support, or 
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“ground”, and allowed to deform and move with respect to the ground in response to the 
displacement input. The simulation then output the time-varying stresses in the bio-bot structure 
as well as the time varying reaction force from the ground. These time-varying reaction forces 
were analyzed in order to understand the structure’s mechanism of motion (Figures 4.10, 4.11). 















































Figure 4.10: Electrically stimulated locomotion of representative symmetric and asymmetric 
bio-bot over a period of 10 seconds (1Hz stimulation frequency). The asymmetric bio-bot 
demonstrated greater displacement in response to electrical stimulation.  
 
Figure 4.11: Reaction forces on representative A) symmetric and B) asymmetric bio-bots from 
ground during electrically stimulated actuation of bioactuators 
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 To explain the bio-bot mechanism of motion, two phenomena and their significance in 
locomotive behavior were considered: 1) The range of motion experienced by the left and right 
pillars of the bio-bot, 2) the phase delay between the contractile response and time-varying 
coefficients of friction in the left and right pillars of the bio-bot. A combination of these two 
phenomena was used to describe the various types of locomotion observed in the bio-bots. For 
the representative samples of symmetric and asymmetric bio-bots considered in detail in this 
study, the active tension analysis and simulations of walking motion led to an improved 
understanding of the mechanism of locomotion. 
 The symmetric bio-bot demonstrated net locomotion in the direction opposite to the 
pillar with a greater range of locomotion (L/R > 1). In this case, the phase-delayed contraction 
caused the left pillar to initially remain static with respect to the ground while the right pillar 
slipped, followed by sliding of the left pillar towards the right. This was termed a “pushing” 
mechanism of locomotion. The asymmetric bio-bot demonstrated net locomotion in the same 
direction as the pillar with a greater range of locomotion (L/R > 1). In this case, the phase-
delayed contraction caused the right pillar to initially remain static with respect to the ground 
while the left pillar slipped, followed by sliding of the right pillar in the direction of motion. This 
was termed a “pulling” mechanism of locomotion. All the bio-bots considered in this study were 
described by either this pushing or pulling mechanism of locomotion (Figure 4.12). 
 
Figure 4.12: Schematic of mechanism of locomotion of all electrically paced symmetric and 
asymmetric skeletal muscle bio-bots stimulated during this study. 
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4.3.5 OPTOGENETIC SKELETAL MUSCLE BIO-BOT 
 Optogenetic skeletal muscle cells which have been genetically engineered to express a 
light-activated cation channel, Channelrhodopsin-2, contract in response to pulsed blue (490 nm) 
light, enabling targeted and noninvasive muscle actuation in real time.  
 In this study, optogenetic skeletal muscle cells were plated in a dish as a 2D monolayer 
and cultured in differentiation media containing 50 ng/mL IGF over a period of two weeks. The 
cells had formed mature myotubes by Day 6 of culture and demonstrated paced contractile 
response to optical stimulation at different frequencies on Day 8 of culture. 
 Based on these results, it was hypothesized that fibrin and collagen based bio-bots 
containing optogenetic skeletal muscle cells would form light-responsive myotubes that contract 
in response to pulsed blue light and demonstrate net locomotion in response to optical 
stimulation. A few representative cases of these optogenetic skeletal muscle bio-bots were 
engineered and analyzed in a similar fashion to the electrically paced skeletal muscle bio-bots 
discussed in the preceding sections.  
On average, optogenetic bio-bots with beam stiffness of 319.4 kPa generated passive 
tension forces similar to those seen in prior studies for both collagen and fibrin based muscle 
strips. However, collagen-based muscle strips were observed to be less robust and snapped 
before Day 12 of culture. Fibrin-based muscle strips seeded around symmetric bio-bots 
demonstrated maximum dynamic active tension forces of 12.34, 13.65, 10.49, and 9.44 µN in 
response to optical stimulation of 1, 2, 3, and 4 Hz stimulation respectively. This force-frequency 
relationship is similar to that observed in electrical stimulation of muscle strips, as discussed in 
Section 4.3.2.  
Individual bio-bots were stimulated both electrically and optically to generate a 
comparison of the active tension force generated in response to differing types of stimulation. 
These studies revealed that bio-bots generated the same active tension responses in response to 
both types of signaling, indicating that the force-generating capacity of optically stimulated bio-
bots is functionally comparable to electrically stimulated bio-bots (Figure 4.13). Of the 
symmetric bio-bots that demonstrated net locomotion in response to optical stimulation, a 
maximum velocity of 5 µm s-1 was observed. It is anticipated that introducing asymmetry into 
the bio-bot structure, as discussed in the Section 4.3.3, will result in greater net displacement. 
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Figure 4.13: Optically stimulated contraction of engineered skeletal muscle yields active tension 
values that are comparable with electrically stimulated contraction of the same muscle strip. 
 
4.3.6 OPTOGENETIC CARDIAC MUSCLE BIO-BOT 
 Optogenetic human embryonic kidney cells (HEK293T) that have been transfected to 
express Channelrhodopsin-2 (ChR2) were co-cultured with neonatal rat ventricular 
cardiomyocytes extracted as described in Section 4.2.4. It was hypothesized that the transfected 
kidney cells would form electrical gap junctions via the Connexin-43 protein when co-cultured 
with primary cardiomyocytes, triggering light-activated action potentials across the engineered 
cardiac muscle. Response of the co-culture system to optical stimulation was observed in 2D, 
where the cardiac and HEK cells were seeded on a poly (ethylene glycol) cantilever and optical 
stimulation was used to drive contraction of the engineered muscle tissue. 
 Based on this preliminary study, collagen-based 3D muscle strips with a co-culture 
containing 90% cardiomyocytes and 10% ChR2 HEK293T cells were seeded around hydrogel 
bio-bot structures with a beam stiffness of 319.4 kPa. The cardiac muscle formed highly 
compacted strips, but did not generate sufficient passive tension force to significantly deform of 
the compliant hydrogel beam (Figure 4.14). Electrical stimulation of these muscle strips resulted 
in observable local contractile response to cells, but not enough macro-scale contractile response 
of the tissue to result in significant deformation of the hydrogel beam. No net locomotion was 
observed. 
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Figure 4.14: Collagen-based 3D cardiac muscle strips contain viable cells that respond to 
electrical stimulation signals. Macro-scale force generation and contractility was not observed. 
 
4.4 DISCUSSION 
 The goal of building biological machines, or bio-bots, capable of demonstrating net 
locomotion in response to external signals has myriad applications including drug delivery, non-
invasive surgery, and biocompatible microelectronic devices. The skeletal and cardiac muscle 
bio-bots presented in this study are capable of contractility and force generation in response to 
electrical and optical external signals. The flexion of the microfabricated soft hydrogel structure 
in response to contraction of the engineered muscle resulted in net locomotion of bio-bots across 
a substrate. 
 
4.4.1 FORCE GENERATION AND CONTRACTILITY OF SKELETAL MUSCLE BIO-BOTS  
 Microfabrication via 3D printing is a novel technique that allows for great flexibility and 
scalability in the design of biological machines. In this study, a stereolithography apparatus was 
used to polymerize hydrogel structures of precisely defined geometric and material properties. 
The traction forces of cells seeded in a synthetic extracellular matrix caused the hydrogel beam 
of the bio-bot to deform into a passive tension state. This passive tension force generated by 
engineered muscle was computed as a function of the stiffness of the hydrogel beam and a 
positive correlation between increasing beam stiffness and increasing passive tension was 
observed. This indicated that engineered muscle differentiated in a higher stiffness environment 
generates more passive tension force over time, an observation that agrees with the observation 
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that mechanical stimulation has been proven to improve the performance engineered skeletal 
muscle (Powell 2002). Experiments on the effect of human insulin-like growth factor, IGF-1, on 
passive tension were conducted and observed to cause an increase in the force generated by the 
engineered muscle. While incorporation of anti-fibrinolytic agents such as aminocaproic acid 
(ACA) into the differentiation medium improved the mechanical integrity and long-term stability 
of the muscle strip, an increase in ACA concentration led to a decrease in passive tension force 
generated by the muscle strip. Similarly, an increase in the cell concentration caused an increase 
in passive tension force, corresponding to the greater number of myotubes formed in the 
engineered muscle strip. This is an interesting and novel advantage of biological machines over 
conventional systems, as the dynamic response and evolution of living cells and components 
allows for a greater variety of functional responses. 
 Both electrical and optical signals were used to stimulate contraction of engineered 
skeletal muscle and the resultant active tension behavior were observed in bio-bots cultured in 
differentiation medium cultured with IGF-1. The magnitude of active tension forces above 
baseline passive tension was shown to decrease with increasing frequency of stimulation. This 
observation seemed to contradict the physiological behavior of skeletal muscle, which 
demonstrates an increase in force generation with increasing frequency of contraction before 
reaching tetanus. However, the force-frequency relationship observed in the bio-bots can be 
attributed to the viscoelastic behavior of the hydrogel structure that, while behaving as a linear 
elastic material at low strain rates, demonstrates rate-dependent material properties at higher 
strain rates (Anseth 1996). At higher frequencies, there is a greater resistance to deformation of 
the hydrogel structure and hence, it is possible that the active tension force does in fact increase 
with increasing frequency of stimulation. Further work on this platform will include models and 
simulations that more rigorously address the viscoelastic response of the hydrogel structures used 
in these studies. 
 
4.4.2 LOCOMOTIVE RESPONSE OF SKELETAL MUSCLE BIO-BOTS 
 A range of locomotive responses was observed in bio-bots with both symmetric and 
asymmetric geometric designs. On average, the controlled asymmetry of design led to more 
readily controllable directional movement and an increase in the functional performance and 
average velocity of the biological machine.  
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In the bio-bot structures, one pillar generally experienced a greater range of motion than 
the other. The range of motion was determined by two factors: beam curvature and normal force 
from the ground. Beam curvature was dependent on both the force in the muscle strip and the 
moment arm between the muscle strip and the beam. Since both pillars were attached to the same 
muscle strip, the force exerted on each pillar was the same. However, differences in cell/gel 
compaction led to different moment arms in the left and right pillars, causing in greater bending 
on one side of the beam and hence greater pillar displacement on the corresponding side. This 
was more apparent in the asymmetric bio-bot structures, as the increased length of one pillar 
generally corresponded to an increase in the moment arm of the muscle strip attached to that 
pillar. The normal force from the ground regulated the frictional force, which in in turn regulated 
the displacement of the pillar. As the bio-bot deformed and walked in response to electrical 
stimulation, the asymmetric distribution of mass in the muscle strip shifted and the weight borne 
by each pillar varied as a function of time. This caused a time varying normal force reaction 
response from the ground, and hence a time varying friction force on the pillars. A combination 
of these two factors determined which pillar experienced a greater range of motion.  
In the bio-bot structures, directional motion occurred when differential coefficients of 
friction between the left and right legs caused one leg to “stick” and the other to “slide” with 
respect to the ground. This differential coefficient of friction between the legs was a result of a 
phase delay between the contractile response of the left and right legs in response to electrical 
stimulation. This phase delay was attributed to the fact that macro-scale contractile response is a 
sum of multiple micro-scale local responses of myotubes responding to electrical stimulation. 
The summed contractile response of individual myotubes distributed throughout the muscle strip 
determined the structure-wide response. 
 As discussed in section 4.3.4, the asymmetric design led to a greater difference in range 
of motion of the different pillars of the bio-bot as well as a greater discrepancy in the time-
varying coefficients of friction of the bio-bot pillars. These factors led to a greater functional 
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4.4.3 OPTOGENETIC CONTROL OF SKELETAL AND CARDIAC MUSCLE BIO-BOTS 
 Optogenetic control of engineered muscle based biological machines allows for non-
invasive external signaling to drive locomotion of bio-bots. In this experiment, methods for 
controlling both skeletal and cardiac muscle based bio-bots were explored and characterized. 
 Optogenetic skeletal muscle cells transfected to express a light sensitive ion channel, 
Channelrhodopsin-2, were incorporated into the 3D fibrin and collagen based muscle strips 
developed in the electrical stimulation portion of the study. These muscle strips showed a similar 
ability to generate force and demonstrate contractile behavior in response to both electrical and 
optical signals. On average, the maximum magnitude of active tension force generated by optical 
stimulation of the optogenetic skeletal muscle symmetric bio-bots at 1 Hz was 12.34 µN. The 
bio-bots demonstrated similar functional responses to optical stimulation as compared to 
electrical stimulation. The maximum velocity demonstrated by optically stimulated symmetric 
bio-bots was 5 µm s-1, a value which falls within the range of velocities demonstrated by 
symmetric bio-bots stimulated via electrical pacing.  
 The low yield and inability to repetitively use primary cardiomyocytes that have 
undergone direct transfection to express light-sensitive ion channels made this an inefficient 
method for producing optogenetic cardiac muscle based bio-bots. To that end, a simpler and 
more efficient method for was developed by transfecting human embryonic kidney cells to 
express ChR2 and co-culturing these cells with cardiomyocytes to form electrical gap junctions 
via the Connexin-43 protein (McSpadden 2009). In this study, optogenetic HEK293T cells were 
co-cultured with primary cardiomyocytes and the electrical coupling between these two cell 
types in the engineered cardiac muscle tissue was shown to display contractile response to 
optical stimuli. However, 3D muscle strips containing similar co-culture of cells only displaced 
local response to stimulation, with no macro-scale contraction of the tissue and resultant 
locomotion of the bio-bot structure. This was attributed to the fact that viability of primary 
cardiomyocytes following the extraction procedure is generally low. When these co-cultures are 
plated in a substrate in 2D, the dead cells are washed away and only living cells survive and 
proliferate across the substrate, generative action potentials that traverse the entire cell sheet and 
are paced by optical stimuli. By contrast, in 3D muscle strips, the dead cells are trapped within 
the muscle strip and decrease the cell to matrix ratio of the engineered muscle. This results in a 
decreased ability to generate macro-scale contractile force. Further optimization of the extraction 
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and seeding protocol is expected to improve the response of optogenetic cardiac muscle bio-bots 
to optical signals. It is anticipated that the high cell density resulting from tissue compaction into 




Tissue engineering has introduced a new set of materials into the human toolbox: living 
cells and biological signals. This enables an array of exciting new technologies. The dynamic 
nature of living components to perform myriad sensing and actuation tasks can be harnessed to 
forward engineer biological machines. In this study, skeletal and cardiac muscle based bio-bots 
were engineered to generate force and produce motion in response to external stimuli. Novel 
methods of measuring the contractile force generated by the engineered muscle were generated 
and executed. The mechanism of motion of skeletal-muscle based bio-bots in response to 
electrical pacing was characterized using a finite element analysis solution.  
Genetic modification was used to transfect mammalian cells with light-gated ion 
channels that allow for the high specificity and spatiotemporal resolution of optical stimulation, 
as compared to electrical signaling. This optical stimulation was used to drive locomotion of 
skeletal muscle based bio-bots and shown to result in contractile behavior of cardiac muscle 
based bio-bots. The bio-bots engineered in this study promise to establish a basis for the design 
rules and principles that govern building biological machines that can sense external signals, 
process them, and demonstrate a controlled locomotive response to them. Bio-bots that can 
dynamically respond to environmental cues in this manner have a wide array of applications, 
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CHAPTER 5: CONCLUSION AND FUTURE DIRECTIONS 
 
5.1 PROJECTION MICRO-STEREOLITHOGRAPHY APPARATUS 
 Microfabrication via 3D printing is a novel technique that allows for flexibility and 
scalability of design with precisely defined geometric and material properties. In this study, a 
stereolithographic apparatus was used to pattern highly porous and absorbent poly (ethylene 
glycol) hydrogels at very high resolution, on the order of single cells in the body. These 
hydrogels promoted the viability and proliferation of encapsulated cells and promise to provide 
an integrative platform for engineering in vitro substitutes for native tissue and organs.  
 
5.1.1 INTEGRATED DEP-µSLA SYSTEM  
In the current µSLA, cells are mixed in a pre-polymer solution and assumed to distribute 
evenly throughout the solution. As the projected light polymerizes patterns in the pre-polymer, 
cells are encapsulated immediately with no further control of patterning. Since the feature sizes 
being patterned are on the order of single cells, a cell positioned in an improper location can 
reduce the fidelity of high-resolution patterning with this apparatus. Researchers have 
demonstrated the ability to control the positioning of live cells in patterned hydrogels using 
patterning (Hynd 2007, Chan 2012), optical trapping of live cells followed by encapsulation in 
photopolymerizable hydrogels (Chiou 2005, Mirsaidov 2008, Linnenberger 2013), 
dielectrophoretic control of live cells followed by encapsulation in photopolymerizable 
hydrogels (Fan 2008, Bajaj 2012), and even magnetic cell levitation in 3D hydrogel tissue 
culture systems (Souza 2010). While these techniques are promising, they come with many 
challenges and disadvantages. For example, optical trapping requires the use of multiple optical 
tweezers to organize cells into complex arrays prior to encapsulation in photosensitive polymeric 
hydrogels. While this technique allows for precise patterning of cells in hydrogels, it is limited 
by the number of cells that can be trapped at a time and requires specifying the position of 
individual cells, a degree of precision that is not often necessary.  
Dielectrophoresis (DEP) based approaches for precision patterning of cells allow for a 
more efficient approach to manipulating and patterning cells. In this approach, cells align along 
specified directional patterns in response to the electrical fields generated by patterned 
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electrodes. This technique enables the formation of precisely defined cellular patterns in a much 
more high-throughput and parallel process than allowed by optical trapping or similar single-cell 
based approaches. For this reason, it is anticipated that the projection micro-stereolithography 
apparatus, µSLA, described in Chapter 3 can be further improved by incorporating DEP 
electrodes into the platform of the polymerization stage (Figure 5.1).  
 
Figure 5.1: Schematic of integrated DEP- µSLA system 
 
As the prepolymer-solution containing cells is pipetted onto the hydrophobic 
polymerization stage of the µSLA, the electric fields generated by the transparent Indium tin 
oxide (ITO) electrodes will align and pattern the cells. Once the cells are aligned, they will be 
trapped in place by the ultraviolet light energy induced polymerization of the pattern generated 
by the spatial light modulator (SLM). The methacrylated micrometer stage will move up, 
allowing for similar patterning and encapsulation of cells in subsequent layers of the 3D design. 
This approach, in addition to allowing patterning of cells in 3D in a massively parallel fashion, 
also avoids exposure of the encapsulated cells to multiple electrical and optical field exposures, 
preserving long term viability. The engineered tissues that can be created this system will have 
micro-scale feature sizes and precisely defined morphological and functional properties in 3D, 
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5.1.2 APPLICATIONS OF µSLA SYSTEM  
Applications of the µSLA extend far beyond the scope of the studies covered in this 
document. Previous studies with the macro-scale SLA have demonstrated the ability of 
fibroblasts encapsulated in hydrogel micro-well “patches” to secrete angiogenic factors and 
pattern blood vessels in vitro (Jeong 2012). These patches are limited in their ability to generate 
a high flux of angiogenic factors because the microwell diameter cannot be decreased with the 
current SLA apparatus without exceeding the resolution limits of the system. The µSLA can, 
however, pattern patches with much smaller feature sizes than capable with the SLA. Future 
studies of such microfabricated patches implanted in vivo can, therefore, could lead to the 
generation of high fidelity perfusable vascular networks. 
 The µSLA was built as a replacement for the existing macro-scale SLA apparatus that 
was used to fabricate the bio-bots used in this study. Future generations of bio-bots that target in 
vivo applications will need to be scaled down in order to traverse the microvasculature of the 
body. Using the micro-scale patterning abilities of the µSLA, bio-bots with feature sizes ten-fold 
smaller than capable with the existing SLA can be fabricated. Features that allow for 
incorporation of multiple cell types can be patterned into the hydrogel structure as well. For 
example, bio-bots that incorporate neurons, as shall be discussed in the following section, will 
require long channels of small diameter through which the axons can be guided to the engineered 
muscle strip.  Furthermore, bio-bots that must function in diverse and non-ideal environments 
will require microfabricated soft hydrogel exoskeletons that insulate the bio-bot and provide 
them with a supply of nutrients. These and other fabrication challenges can only be rendered 
possible by the precision patterning capabilities of the µSLA.  
 
5.1.3 CONCLUSION 
 Digital mask based projection stereolithography offers many advantages over currently 
existing techniques for patterning cells and cell signals in 3D. The µSLA system illustrated in 
this thesis has the ability to fabricate biocompatible structures with feature sizes that enable a 
wide array of applications including studies of cell mechanics, programmable tissue engineering, 
and the development of biological machines and promises to be an indispensible enabling tool in 
the field of bionanotechnology in the coming years. 
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5.2 MICROFABRICATED BIOLOGICAL MACHINES  
 Forward-engineered biological machines and systems with the ability to dynamically 
sense, process, and respond to external cues define a promising new era of soft robotics. The 
most intuitive demonstration of controllable behavior is stimulation-induced actuation and 
locomotion. In this study, biological machines microfabricated via stereolithography served as a 
platform for the force generation and contractile behavior of engineered skeletal and cardiac 
muscle. Electrical signals were used to pace and drive contraction of this engineered muscle in 
the first stage of the study, followed by the more precise noninvasive technique of optical 
signaling enabled by the emerging field of optogenetics. 
 
5.2.1 FURTHER DEVELOPMENTS IN OPTOGENETIC STIMULATION 
 In this study, the light-gated Channelrhodopsin-2 ion channel was used to stimulate 
contraction of engineered muscle in response to blue light of 490 nm wavelength. In muscle 
tissue that does not demonstrate spontaneous/autonomous contraction, this light-gated channel is 
sufficient to drive control of the biological machines. However, in muscle tissue that does 
demonstrate significant autonomous contractile forces, such as those observed in cardiac muscle 
tissue, a light-activated anion channel that can suppress these action potentials is required. The 
next step in engineering optogenetically controlled machine with start/stop control is thus the 
incorporation of the light gated anion channel, halorhodopsin (NpHR), into muscle culture 
systems via transfection. This anion channel is activated by yellow light of 590 nm wavelength 
and, in tandem with the blue light activated ChR2 ion channel, can be used to trigger and 
suppress action potentials in engineered muscle tissue, as required, with high spatiotemporal 
resolution. 
 Currently, an LED connected to a function generator is the source of optical stimulation 
used to drive locomotion of the bio-bots. While this method is functional, it does not take 
advantage of the high specificity and spatiotemporal resolution enabled by the field of 
optogenetics. The advantage of this genetic modification technique is that it can be used to excite 
and pace single muscle cells or portions or whole areas of 2D sheets or 3D strips of engineered 
muscle. To harness these high-resolution capabilities of optogenetic muscle systems, a new 
optical stimulation setup has been built (Figure 5.2). In this setup, a customized script tracks bio-
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bots using a camera using automated tracking software§. A projector and lens system is used to 
project blue or yellow light onto portions or whole areas of the bio-bot, and the stimulus follows 
the bio-bot via during locomotion via the automated tracking system. This novel and 
sophisticated stimulation apparatus allows for precise and dynamic stimulation of engineered 
muscle systems, allowing for the creation of more intricate bio-bot designs and locomotion 
mechanisms in the future. 
 
Figure 5.2: Schematic of apparatus to automatically track and stimulate optogenetic bio-bots 
 
5.2.2 BIOLOGICAL CHARACTERIZATION OF ENGINEERED MUSCLE  
 The bio-bots used in this study have primarily been analyzed from a mechanical 
perspective in this document, but biological analysis of bio-bots is a significant ongoing 
challenge in this field. Histology and immunostaining of skeletal muscle based bio-bots have 
revealed that cells tend to accumulate near the outer periphery of the tissue, within the diffusion 
distance of 150 µm, as reported in many tissue engineered systems (Novosel 2011). Studies of 
this kind have led to qualitative understandings of the morphological organization of engineered 
tissue. For example, staining of the bio-bot muscle strips analyzed in this study has shown that 
myotubes tend to align in the direction of uniaxial tension imposed by the hydrogel structure and 
more myotubes are observed in bio-bots supplemented with IGF-1.  
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  tracking	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  written	  by	  Michael	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  Professor	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research	  group,	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  Brian	  Williams,	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  Professor	  Taher	  Saif’s	  research	  
group	  at	  the	  University	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  at	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A next step in the characterization of these muscle strips is calcium staining of muscle 
strips during contraction. Calcium staining involves staining the muscle tissue with a voltage 
sensitive dye that fluoresces in response to the calcium ion flow that occurs during an action 
potential. This will allow for precise visualization of action potential propagation across the 
engineered muscle tissue, enabling understanding of the force generation and distribution in the 
macro-scale tissue and motivating newer and more efficient designs (Herron 2012). 
 
5.2.3 INTEGRATION OF MULTIPLE CELL TYPES  
 Bio-bots capable of controlled actuation and locomotion are but the first step in 
engineering biological machines. The goal of these technologies is to create truly integrated 
systems composed of multiple cell types that interact with each other to perform complex 
sensing, processing, and actuation tasks. Following the experiments in which bio-bot mobility is 
controlled via external optical signals, the system detailed in this study will start to incorporate 
optogenetic neurons that interface with the engineered muscle via functional neuromuscular 
junctions. These neurons will be used to initiate action potentials in the engineered muscle that 
will drive contractility, force generation, and ultimate actuation of the biological machines. 
While direct optical stimulation of skeletal muscle as accomplished in the initial experiments 
will provide “on” or “off” control of bio-bots, these integrated cellular systems containing 
neuronal networks interfacing with muscle will enable more complex behavior by processing 
compound signals through neuronal circuits to generate a variety of responses. Eventually, the 
incorporation of endothelial cells into these biological systems will enable the vascularization of 
large bio-bots, allowing for better distribution of cells, cell signals, and nutrients throughout the 
engineered tissue. This is anticipated to lead to more efficient force production in the long term. 
 The mammalian cell based bio-bots engineered in this study function best in the specific 
biochemical and physical environment of culture medium maintained at body temperature, 37ºC. 
In order for bio-bots to be utilized in a variety of applications, they must be robust and capable of 
functioning in diverse and non-ideal environments. A future direction in engineering such robust 
biological machines is the incorporation of microfabricated soft synthetic exoskeletons into the 
bio-bot designs that will provide the machines with insulation and a temporary supply of 
nutrients. This will dramatically increase the ability of bio-bots to be tailored to a myriad array of 
sensing and actuation applications. 
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5.2.4 CONCLUSION  
Forward engineered biological systems have many practical applications and can lead to 
a quantitative understanding of the way integrated cellular systems sense and respond to signals 
in their environment. The skeletal and cardiac muscle based controllable bioactuators presented 
in this thesis represent the first step towards engineering biological machines capable of complex 
functional behaviors. 
 
5.3 A NEW ERA OF DESIGN AND MANUFACTURING 
The burgeoning field of additive manufacturing, or “3D printing”, centers on the idea of 
creating three-dimensional objects from digital models. While conventional manufacturing 
approaches rely on modifying a base material via subtractive processes such as drilling or 
cutting, 3D printing creates three-dimensional objects through successive deposition of two-
dimensional layers. By enabling rapid fabrication of complex objects, 3D printing is 
revolutionizing the way we think about design and manufacturing. 
In stereolithography, a subtype of 3D printing, photopolymers (polymers that change 
their properties in response to light) are patterned or “cured” into three-dimensional designs 
through exposure to ultraviolet light. Conventionally, laser-based stereolithography apparatus 
have used visible or ultraviolet light lasers to trace 2D cross-sections of 3D designs, building 
complex structures layer by layer from the bottom up. More recently, projection-based 
stereolithography apparatus have demonstrated the ability to project high resolution 2D light 
patterns onto photopolymers, allowing for rapid fabrication of complex structures with reduced 
feature sizes.   
Many researchers have explored the use of laser-based stereolithographic 
microfabrication technologies as a method of printing living cells dispersed in highly absorbent 
hydrogel polymer matrix. This thesis details the development of a projection-based 
stereolithography apparatus capable of patterning cells and cell signals at high resolution in vitro. 
This novel enabling technology can be used to create model cellular systems that lead to a 
quantitative understanding of the way cells sense, process, and respond to signals in their 
environment.  
The emerging field of tissue engineering promises to revolutionize modern medicine by 
providing an alternative to tissue and organ transplantation through the creation of in vitro model 
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systems that can replicate the structure and function of native tissue. While the goal of “reverse 
engineering” native tissue is promising for medical applications, this idea of building with 
biology concurrently brings about a new field: “forward engineering” of biological machines and 
systems. In addition to rebuilding existing systems with cells, researchers can also design and 
forward engineer novel systems that harness the innate dynamic abilities of cells to self-organize, 
self-heal, and self-replicate in response to environmental cues. These machines, which can sense, 
process, and respond to signals in a dynamic environment, have a myriad array of applications 
including toxin neutralization and high throughput drug testing in vitro and drug delivery and 
programmable tissue engineered implants in vivo. 
 Throughout history, humans have designed and built machines and systems using 
“traditional” engineering materials such as wood, metals, and plastics through subtractive 
manufacturing techniques. The advent of 3D printing additive manufacturing technologies has 
ushered in a new age of design in which increased complexity of structures and reduced material 
waste is enabled. Concurrently, the idea of “building with biology”, or using cells and instructive 
biomaterials as building blocks for constructing complex biological substitutes for native tissue, 
has garnered much momentum. A synthesis of these two fields brings about a new era of 
technological innovation: using microfabrication technologies to forward engineer biological 
machines and systems capable of complex functional behavior. By introducing a new set of 
“building blocks” into the engineer’s toolbox, this new era of design and manufacturing promises 
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